ATSAUCĒ IETVERT:
Par izmaiņām Kompensējamo zāļu sarakstā. Publicēts oficiālajā laikrakstā "Latvijas Vēstnesis", 10.06.2011., Nr. 91 https://www.vestnesis.lv/ta/id/231480
RĪKI
Tiesību aktu un oficiālo paziņojumu oficiālā publikācija pieejama laikraksta "Latvijas Vēstnesis" drukas versijā.
Veselības ekonomikas centra rīkojums Nr.76
Rīgā 2011.gada 8.jūnijā
Par izmaiņām Kompensējamo zāļu sarakstā
Izdots saskaņā ar Ministru kabineta
2006.gada 31.oktobra noteikumu Nr.899
"Ambulatorajai ārstēšanai paredzēto zāļu un medicīnisko
ierīču
iegādes izdevumu kompensācijas kārtība" 10., 53., 54., 61.
un 64. punktu
1. Pamatojoties uz Veselības ekonomikas centra pieņemtajiem lēmumiem no 02.05.2011. līdz 07.06.2011. par zāļu un medicīnisko ierīču iekļaušanu, saraksta kategorijas pārskatīšanu, kompensācijas bāzes cenas pārskatīšanu, references cenas pārskatīšanu, svītrošanu, zāļu identifikācijas numuru maiņu Kompensējamo zāļu sarakstā (turpmāk tekstā – Saraksts):
1.1. Iekļaut Sarakstā zāles (1.pielikums "Kompensējamo zāļu sarakstā iekļautās zāles");
1.2. Iekļaut Sarakstā medicīniskās ierīces (2.pielikums "Kompensējamo zāļu sarakstā iekļautās medicīniskās ierīces");
1.3. Mainīt Sarakstā kompensācijas bāzes cenu un/vai references cenu zālēm (3.pielikums "Kompensācijas bāzes cenas un/vai references cenas maiņa Kompensējamo zāļu saraksta zālēm");
1.4. Mainīt Sarakstā kompensācijas bāzes cenu medicīniskajām ierīcēm (4.pielikums "Kompensācijas bāzes cenas un/vai references cenas maiņa Kompensējamo zāļu saraksta medicīniskajām ierīcēm");
1.5. Mainīt Sarakstā saraksta kategoriju zālēm (5.pielikums "Saraksta kategorijas maiņa Kompensējamo zāļu saraksta zālēm");
1.6. Mainīt Sarakstā identifikācijas numuru zālēm (6.pielikums "Identifikācijas numura maiņa Kompensējamo zāļu saraksta zālēm");
1.7. Svītrot no Saraksta zāles (7.pielikums "No Kompensējamo zāļu saraksta svītrotās zāles");
1.8. Svītrot no Saraksta medicīniskās ierīces (8.pielikums "No Kompensējamo zāļu saraksta svītrotās medicīniskās ierīces").
2. Rīkojums stājas spēkā 2011.gada 1.jūlijā.
Veselības ekonomikas centra direktore D.Behmane
1.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
Kompensējamo zāļu sarakstā iekļautās zāles
|
Zāļu vispārīgais nosaukums |
ATC kodi |
Medikamenta identifikācijas Nr. |
Zāļu nosaukums |
Reģistrācijas apliecības īpašnieks |
Forma |
Stiprums mg |
Iepakojuma lielums |
Kompensācijas bāzes cena (Ls) |
Aptiekas cena ar PVN |
Kompensācijas summa (Ls) |
Saraksta kategorija |
Medikamenta pazīme |
||
|
100% |
75% |
50% |
||||||||||||
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
| Amisulpridum |
N05AL05 |
I000144-01 |
Solian 400mg | ELPIS SIA (paralēlais importētājs) | apvalkotas tabletes |
400 |
30 |
27,65 |
34,47 |
34,47 |
25,85 |
17,24 |
B |
P |
| Amlodipinum/ Valsartanum/ Hydrochloro-thiazidum |
C09DX01 |
EU/1/09/569/002 |
Exforge HCT | Novartis Europharm Limited | apvalkotas tabletes |
5/160/ 12.5 |
28 |
17,68 |
22,70 |
9,34 |
7,01 |
4,67 |
A |
|
|
C09DX01 |
EU/1/09/569/014 |
Exforge HCT | Novartis Europharm Limited | apvalkotas tabletes |
10/160/ 12.5 |
28 |
19,19 |
24,51 |
10,46 |
7,85 |
5,23 |
A |
|
|
| Anagrelidum |
L01XX35 |
04-0076-01 |
Thromboreductin 0,5mg | Orpha Devel Handels GmbH | kapsulas |
0,5 |
100 |
238,89 |
272,32 |
272,32 |
204,24 |
136,16 |
B |
|
| Aprepitantum |
A04AD12 |
EU/1/03/262/006 |
Emend | Merck Sharp & Dohme Ltd. | cietas kapsulas |
125+80 |
3 |
37,47 |
46,02 |
46,02 |
34,52 |
23,01 |
B |
|
| Atorvastatinum |
C10AA05 |
10-0489-07 |
Atorgamma 20mg | Worwag Pharma GmbH & Co.KG | apvalkotas tabletes |
20 |
30 |
2,38 |
3,37 |
3,37 |
2,53 |
1,69 |
A |
R |
|
C10AA05 |
10-0607-01 |
Atoris 80mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
80 |
30 |
14,18 |
18,48 |
13,20 |
9,90 |
6,60 |
A |
|
|
| Bimatoprostum |
S01EE03 |
EU/1/02/205/002 |
Lumigan | Allergan Pharmaceuticals Ireland | acu pilieni, šķīdums |
0.3mg/ ml-3ml |
3 gab. |
22,66 |
28,60 |
20,33 |
15,25 |
10,17 |
A |
|
| Bimatoprostum/ Timololum |
S01ED51 |
EU/1/06/340/002 |
Ganfort | Allergan Pharmaceuticals Ireland | acu pilieni, šķīdums |
0.3/5mg/ml-3ml |
3 gab. |
27,71 |
34,55 |
23,60 |
17,70 |
11,80 |
A |
|
| Clarithromycinum |
J01FA09 |
06-0002-01 |
Clarithromycin-Teva 250mg | Teva Pharma B.V. | apvalkotas tabletes |
250 |
14 |
4,49 |
6,22 |
6,22 |
4,67 |
3,11 |
A |
R |
|
J01FA09 |
06-0003-01 |
Clarithromycin-Teva 500mg | Teva Pharma B.V. | apvalkotas tabletes |
500 |
14 |
7,41 |
9,99 |
9,99 |
7,49 |
5,00 |
A |
R |
|
|
J01FA09 |
10-0609-01 |
Klacid 500mg | Abbott Laboratories Baltics SIA | apvalkotas tabletes |
500 |
14 |
8,07 |
10,84 |
9,99 |
7,49 |
5,00 |
A |
|
|
| Darunavirum |
J05AE10 |
EU/1/06/380/002 |
Prezista | Janssen-Cilag International NV | apvalkotas tabletes |
600 |
60 |
433,47 |
490,25 |
490,25 |
367,69 |
245,13 |
B |
|
| Denosumabum |
M05BX04 |
EU/1/10/618/003 |
Prolia | Amgen Europe B.V. | šķīdums injekcijām |
60mg/ml |
1 |
144,78 |
166,91 |
60,41 |
45,31 |
30,21 |
A |
|
| Dienogestum |
G03D |
10-0059-01 |
Visannette 2mg | Bayer Schering Pharma AG | tabletes |
2 |
28 |
28,51 |
35,49 |
35,49 |
26,62 |
17,75 |
B |
|
| Docetaxelum |
L01CD02 |
10-0579-01 |
Docetaxel Actavis 20mg/0,5ml | Actavis Group PTC ehf | koncentrāts infūzijām ar šķīdinātāju |
20mg/ 0.5ml |
1 |
29,23 |
36,33 |
36,33 |
27,25 |
18,17 |
A |
R |
|
L01CD02 |
EU/1/95/002/003 |
Taxotere | Aventis Pharma S.A. | koncentrāts infūziju šķīduma pagatavo-šanai |
20mg/ml |
1 |
67,00 |
79,80 |
36,33 |
27,25 |
18,17 |
A |
|
|
|
L01CD02 |
10-0580-01 |
Docetaxel Actavis 80mg/2ml | Actavis Group PTC ehf | koncentrāts infūzijām ar šķīdinātāju |
80mg/ 2ml |
1 |
107,13 |
124,75 |
124,75 |
93,56 |
62,38 |
A |
R |
|
|
L01CD02 |
EU/1/95/002/004 |
Taxotere | Aventis Pharma S.A. | koncentrāts infūziju šķīduma pagatavo-šanai |
80mg/ 4ml |
1 |
241,00 |
274,68 |
124,75 |
93,56 |
62,38 |
A |
|
|
| Dorzolamidum |
S01EC03 |
11-0011-01 |
Dorzolamide Portfarma 20mg/ml | Portfarma ehf | acu pilieni, šķīdums |
20mg/ml-5ml |
1 gab. |
4,74 |
6,55 |
6,55 |
4,91 |
3,28 |
A |
R |
| Doxorubicinum |
L01DB01 |
10-0185-01 |
Doxorubicin Actavis 10mg | Actavis Group PTC ehf | pulveris injekciju šķīduma pagatavo-šanai |
10 |
1 |
2,79 |
3,92 |
3,92 |
2,94 |
1,96 |
A |
R |
|
L01DB01 |
10-0186-01 |
Doxorubicin Actavis 50mg | Actavis Group PTC ehf | pulveris injekciju šķīduma pagatavo-šanai |
50 |
1 |
15,08 |
19,59 |
19,59 |
14,69 |
9,80 |
A |
R |
|
| ECHO-7 virus strain |
L03AX |
04-0229-01 |
Rigvir | Latima SIA | šķīdums injekcijām |
2x106-2x108 CPD50/ ml-2ml |
1 |
42,33 |
51,74 |
51,74 |
38,81 |
25,87 |
B |
|
| Erythropoietinum |
B03XA01 |
EU/1/09/573/003 |
Eporatio | Ratiopharm GmbH | šķīdums injekcijām pilnšļircēs |
2 000IU/ 0.5ml |
6 |
50,15 |
60,93 |
60,93 |
45,70 |
30,47 |
A |
R |
|
B03XA01 |
EU/1/09/573/007 |
Eporatio | Ratiopharm GmbH | šķīdums injekcijām pilnšļircēs |
4 000IU/ 0.5ml |
6 |
99,31 |
115,99 |
115,99 |
86,99 |
58,00 |
A |
R |
|
|
B03XA01 |
EU/1/09/573/009 |
Eporatio | Ratiopharm GmbH | šķīdums injekcijām pilnšļircēs |
5 000IU/ 0.5ml |
6 |
121,87 |
141,25 |
141,25 |
105,94 |
70,63 |
A |
R |
|
|
B03XA01 |
EU/1/09/573/016 |
Eporatio | Ratiopharm GmbH | šķīdums injekcijām pilnšļircēs |
10 000IU/ ml |
6 |
228,02 |
260,14 |
260,14 |
195,11 |
130,07 |
A |
R |
|
|
B03XA01 |
EU/1/09/573/023 |
Eporatio | Ratiopharm GmbH | šķīdums injekcijām pilnšļircē |
30 000IU/ ml |
1 |
113,65 |
132,05 |
132,05 |
99,04 |
66,03 |
A |
R |
|
| Escitalopramum |
N06AB10 |
10-0182-03 |
Norestal 10mg | Norameda UAB | apvalkotas tabletes |
10 |
28 |
4,24 |
5,89 |
5,89 |
4,42 |
2,95 |
A |
R |
|
N06AB10 |
10-0184-03 |
Norestal 20mg | Norameda UAB | apvalkotas tabletes |
20 |
28 |
8,72 |
11,68 |
11,68 |
8,76 |
5,84 |
A |
R |
|
| Exemestanum |
L02BG06 |
11-0045-01 |
Exemestane SanoSwiss 25mg | SanoSwiss UAB | apvalkotas tabletes |
25 |
30 |
45,42 |
55,37 |
54,24 |
40,68 |
27,12 |
A |
|
| Gabapentinum |
N03AX12 |
03-0384-03 |
Gabagamma 100mg | Worwag Pharma GmbH & Co.KG | cietas kapsulas |
100 |
50 |
2,39 |
3,38 |
3,38 |
2,54 |
1,69 |
A |
R |
| Gliclazidum |
A10BB09 |
10-0239-06 |
Gliclazide Actavis 30mg | Actavis Group PTC ehf | ilgstošas darbības tabletes |
30 |
60 |
3,54 |
4,97 |
4,97 |
3,73 |
2,49 |
A |
R |
|
A10BB09 |
09-0536-14 |
Diaprel MR 60mg | Les Laboratoires Servier | ilgstošas darbības tabletes |
60 |
120 |
17,11 |
22,02 |
19,80 |
14,85 |
9,90 |
A |
|
|
| Indacaterolum |
R03AC18 |
EU/1/09/593/002 |
Onbrez Breezhaler | Novartis Europharm Limited | inhalācijas pulveris cietās kapsulās |
0,15 |
30 |
21,05 |
26,71 |
26,71 |
20,03 |
13,36 |
B |
|
|
R03AC18 |
EU/1/09/593/007 |
Onbrez Breezhaler | Novartis Europharm Limited | inhalācijas pulveris cietās kapsulās |
0,3 |
30 |
21,05 |
26,71 |
26,71 |
20,03 |
13,36 |
B |
|
|
| Indapamidum |
C03BA11 |
10-0006-06 |
Indamax 1,5mg | Teva Pharma B.V. | ilgstošas darbības tabletes |
1,5 |
30 |
2,40 |
3,39 |
3,39 |
2,54 |
1,70 |
A |
R |
| Insulinum human |
A10AC01 |
EU/1/97/030/148 |
Insuman Basal SoloStar | Aventis Pharma Deutschland GmbH | suspensija injekcijām pilnšļircēs |
100SV/ ml-3ml |
5 |
13,87 |
18,10 |
18,10 |
13,58 |
9,05 |
B |
|
| Lacidipinum |
C08CA09 |
I000158-01 |
Lacipil 4mg | ELPIS SIA (paralēlais importētājs) | apvalkotas tabletes |
4 |
14 |
2,10 |
2,99 |
2,99 |
2,24 |
1,50 |
A |
R P |
|
C08CA09 |
I000157-01 |
Lacipil 6mg | Scandic Pharma SIA (paralēlais importētājs) | apvalkotas tabletes |
6 |
28 |
7,16 |
9,67 |
9,67 |
7,25 |
4,84 |
A |
R P |
|
| Latanoprostum |
S01EE01 |
10-0502-01 |
Latalux 50mcg/ml | Sanitas AB | acu pilieni, šķīdums |
0.05mg/ml-2.5ml |
1 gab. |
4,92 |
6,79 |
6,79 |
5,09 |
3,40 |
A |
R |
| Lercanidipinum |
C08CA13 |
10-0647-03 |
Lercanidipin Orion 10mg | Orion Corporation | apvalkotas tabletes |
10 |
28 |
4,29 |
5,96 |
5,96 |
4,47 |
2,98 |
A |
R |
| Levothyroxinum |
H03AA01 |
10-0255-03 |
Euthyrox 25mcg | Merck KgaA | tabletes |
0,025 |
90 |
1,95 |
2,79 |
0,93 |
0,70 |
0,47 |
A |
|
| Mesalazinum |
A07EC02 |
10-0562-01 |
Pentasa 1g | Ferring Lääkkeet Oy | ilgstošas darbības granulas |
1000 |
50 |
29,52 |
36,68 |
36,68 |
27,51 |
18,34 |
A |
R |
|
A07EC02 |
10-0563-02 |
Pentasa 2g | Ferring Lääkkeet Oy | ilgstošas darbības granulas |
2000 |
60 |
62,41 |
74,66 |
74,66 |
56,00 |
37,33 |
A |
R |
|
| Metforminum |
A10BA02 |
09-0344-11 |
Glucophage 500mg | Merck Sante s.a.s. | apvalkotas tabletes |
500 |
90 |
2,37 |
3,35 |
2,88 |
2,16 |
1,44 |
A |
|
| Natrii risedronatum |
M05BA07 |
10-0479-03 |
Risedronate sodium Portfarma 35mg | Portfarma ehf | apvalkotas tabletes |
35 |
4 |
6,84 |
9,26 |
9,26 |
6,95 |
4,63 |
A |
R |
| Nebivololum |
C07AB12 |
09-0343-07 |
Nebiphar 5mg | Teva Pharma B.V. | tabletes |
5 |
28 |
2,52 |
3,55 |
3,25 |
2,44 |
1,63 |
A |
|
|
C07AB12 |
08-0138-07 |
Nebivolol Actavis 5mg | Actavis Group PTC ehf | tabletes |
5 |
90 |
7,30 |
9,86 |
9,86 |
7,40 |
4,93 |
A |
R |
|
| Olanzapinum |
N05AH03 |
10-0311-02 |
Olanzapine Orion 5mg | Orion Corporation | mutē disperģēja-mas tabletes |
5 |
28 |
11,02 |
14,58 |
14,58 |
10,94 |
7,29 |
A |
R |
|
N05AH03 |
10-0312-02 |
Olanzapine Orion 10mg | Orion Corporation | mutē disperģēja-mas tabletes |
10 |
28 |
22,03 |
27,87 |
27,87 |
20,90 |
13,94 |
A |
R |
|
|
N05AH03 |
10-0313-02 |
Olanzapine Orion 15mg | Orion Corporation | mutē disperģēja-mas tabletes |
15 |
28 |
33,83 |
41,74 |
41,74 |
31,31 |
20,87 |
A |
R |
|
| Omeprazolum |
A02BC01 |
00-0797-02 |
Omeprazole-ratiopharm 20mg | Ratiopharm GmbH | zarnās šķīstošas cietas kapsulas |
20 |
30 |
3,39 |
4,78 |
4,78 |
3,59 |
2,39 |
B |
|
| Paroxetinum |
N06AB05 |
I000152-01 |
Seroxat 20mg | ELPIS SIA (paralēlais importētājs) | apvalkotas tabletes |
20 |
30 |
10,09 |
13,44 |
8,16 |
6,12 |
4,08 |
A |
P |
| Quetiapinum |
N05AH04 |
07-0335-03 |
Ketilept 300mg | Egis Pharmaceuticals PLC | apvalkotas tabletes |
300 |
30 |
21,74 |
27,53 |
27,53 |
20,65 |
13,77 |
A |
R |
|
N05AH04 |
10-0658-04 |
Ketipinor 300mg | Orion Corporation | apvalkotas tabletes |
300 |
100 |
73,63 |
87,23 |
87,23 |
65,42 |
43,62 |
A |
R |
|
| Rilmenidinum |
C02AC06 |
10-0523-02 |
Rilmenidine Teva 1mg | Teva Pharma B.V. | tabletes |
1 |
30 |
3,12 |
4,42 |
4,42 |
3,32 |
2,21 |
A |
R |
| Ropinirolum |
N04BC04 |
11-0085-02 |
Rolpryna SR 2mg | KRKA d.d., Novo mesto | ilgstošas darbības tabletes |
2 |
28 |
7,36 |
9,92 |
9,92 |
7,44 |
4,96 |
A |
R |
|
N04BC04 |
11-0085-04 |
Rolpryna SR 2mg | KRKA d.d., Novo mesto | ilgstošas darbības tabletes |
2 |
84 |
23,02 |
29,03 |
29,03 |
21,77 |
14,52 |
A |
R |
|
|
N04BC04 |
06-0263-03 |
Requip-Modutab 4mg | GlaxoSmithKline Latvia SIA | ilgstošas darbības tabletes |
4 |
28 |
15,43 |
20,00 |
19,82 |
14,87 |
9,91 |
A |
|
|
|
N04BC04 |
11-0086-04 |
Rolpryna SR 4mg | KRKA d.d., Novo mesto | ilgstošas darbības tabletes |
4 |
84 |
47,45 |
57,76 |
57,76 |
43,32 |
28,88 |
A |
R |
|
|
N04BC04 |
11-0087-04 |
Rolpryna SR 8mg | KRKA d.d., Novo mesto | ilgstošas darbības tabletes |
8 |
84 |
93,25 |
109,20 |
109,20 |
81,90 |
54,60 |
A |
R |
|
| Rosuvastatinum |
C10AA07 |
10-0162-04 |
Rosuvastatin Teva 10mg | Teva Pharma B.V. | apvalkotas tabletes |
10 |
28 |
3,64 |
5,11 |
4,73 |
3,55 |
2,37 |
A |
|
|
C10AA07 |
11-0027-04 |
Sorvasta 10mg | Medical Marketing Consulting SIA | apvalkotas tabletes |
10 |
28 |
4,73 |
6,53 |
4,73 |
3,55 |
2,37 |
A |
|
|
|
C10AA07 |
10-0163-04 |
Rosuvastatin Teva 20mg | Teva Pharma B.V. | apvalkotas tabletes |
20 |
28 |
7,59 |
10,23 |
9,41 |
7,06 |
4,71 |
A |
|
|
|
C10AA07 |
11-0029-04 |
Sorvasta 20mg | Medical Marketing Consulting SIA | apvalkotas tabletes |
20 |
28 |
8,88 |
11,88 |
9,41 |
7,06 |
4,71 |
A |
|
|
|
C10AA07 |
11-0031-04 |
Sorvasta 40mg | Medical Marketing Consulting SIA | apvalkotas tabletes |
40 |
28 |
12,59 |
16,50 |
16,50 |
12,38 |
8,25 |
A |
R |
|
| Somatropinum |
H01AC01 |
97-0643-08 |
Zomacton 4mg | Ferring GmbH | pulveris injekcijām ar šķīdinātāju |
4 |
1 |
62,86 |
75,16 |
47,07 |
35,30 |
23,54 |
A |
|
|
H01AC01 |
10-0011-01 |
Zomacton 10mg | Ferring GmbH | pulveris injekcijām ar šķīdinātāju |
10 |
1 |
155,64 |
179,08 |
117,65 |
88,24 |
58,83 |
A |
|
|
| Telmisartanum |
C09CA07 |
EU/1/10/639/012 |
Telmisartan Actavis | Actavis Group PTC ehf | tabletes |
40 |
28 |
4,03 |
5,62 |
3,02 |
2,27 |
1,51 |
A |
|
|
C09CA07 |
EU/1/10/639/022 |
Telmisartan Actavis | Actavis Group PTC ehf | tabletes |
80 |
28 |
5,93 |
8,09 |
6,02 |
4,52 |
3,01 |
A |
|
|
| Telmisartanum/ Amlodipinum |
C09DB04 |
EU/1/10/648/002 |
Twynsta | Boehringer Ingelheim International GmbH | tabletes |
40/5 |
28 |
14,84 |
19,29 |
4,95 |
3,71 |
2,48 |
A |
|
|
C09DB04 |
EU/1/10/648/009 |
Twynsta | Boehringer Ingelheim International GmbH | tabletes |
40/10 |
28 |
15,73 |
20,36 |
6,07 |
4,55 |
3,04 |
A |
|
|
|
C09DB04 |
EU/1/10/648/016 |
Twynsta | Boehringer Ingelheim International GmbH | tabletes |
80/5 |
28 |
17,93 |
23,00 |
7,94 |
5,96 |
3,97 |
A |
|
|
|
C09DB04 |
EU/1/10/648/023 |
Twynsta | Boehringer Ingelheim International GmbH | tabletes |
80/10 |
28 |
18,82 |
24,07 |
9,06 |
6,80 |
4,53 |
A |
|
|
| Topiramatum |
N03AX11 |
10-0301-01 |
Topiramate Pfizer 25mg | Pfizer Europe MA EEIG | apvalkotas tabletes |
25 |
60 |
4,40 |
6,10 |
6,10 |
4,58 |
3,05 |
A |
R |
|
N03AX11 |
10-0507-03 |
Topiramate Portfarma 25mg | Portfarma ehf | apvalkotas tabletes |
25 |
60 |
4,40 |
6,10 |
6,10 |
4,58 |
3,05 |
A |
R |
|
|
N03AX11 |
10-0302-01 |
Topiramate Pfizer 50mg | Pfizer Europe MA EEIG | apvalkotas tabletes |
50 |
60 |
9,12 |
12,20 |
12,20 |
9,15 |
6,10 |
A |
R |
|
|
N03AX11 |
10-0508-03 |
Topiramate Portfarma 50mg | Portfarma ehf | apvalkotas tabletes |
50 |
60 |
9,12 |
12,20 |
12,20 |
9,15 |
6,10 |
A |
R |
|
|
N03AX11 |
10-0303-01 |
Topiramate Pfizer 100mg | Pfizer Europe MA EEIG | apvalkotas tabletes |
100 |
60 |
17,52 |
22,51 |
22,51 |
16,88 |
11,26 |
A |
R |
|
|
N03AX11 |
10-0509-03 |
Topiramate Portfarma 100mg | Portfarma ehf | apvalkotas tabletes |
100 |
60 |
17,52 |
22,51 |
22,51 |
16,88 |
11,26 |
A |
R |
|
|
N03AX11 |
10-0510-03 |
Topiramate Portfarma 200mg | Portfarma ehf | apvalkotas tabletes |
200 |
60 |
36,52 |
44,91 |
44,91 |
33,68 |
22,46 |
A |
R |
|
| Topotecanum |
L01XX17 |
EU/1/09/552/002 |
Topotecan Teva | Teva Pharma B.V. | koncentrāts infūziju šķīduma pagatavo-šanai |
1mg/ml |
5 |
139,50 |
161,00 |
161,00 |
120,75 |
80,50 |
A |
R |
| Triptorelinum |
L02AE04 |
I000164-01 |
Diphereline SR 3,75mg | ELPIS SIA (paralēlais importētājs) | ilgstošas darbības pulveris un šķīdinātājs injekciiju suspenijas pagatavo-šanai |
3,75 |
1 |
62,42 |
74,67 |
74,67 |
56,00 |
37,34 |
B |
P |
|
L02AE04 |
I000163-01 |
Diphereline SR 11,25mg | ELPIS SIA (paralēlais importētājs) | ilgstošas darbības pulveris un šķīdinātājs injekciiju suspenijas pagatavo-šanai |
11,25 |
1 |
194,90 |
223,05 |
223,05 |
167,29 |
111,53 |
B |
P |
|
|
L02AE04 |
I000165-01 |
Diphereline SR 11,25mg | Scandic Pharma SIA (paralēlais importētājs) | ilgstošas darbības pulveris un šķīdinātājs injekciiju suspenijas pagatavo-šanai |
11,25 |
1 |
194,90 |
223,05 |
223,05 |
167,29 |
111,53 |
B |
P |
|
| VIII asinsreces faktors |
B02BD02 |
10-0495-01 |
Human Coagulation Factor VIII 250 IU | Baltijas Terapeitiskais Serviss | pulveris un šķīdinātājs injekciju šķīduma pagatavo-šanai |
250SV/ 2.5ml |
1 |
27,61 |
34,43 |
34,43 |
25,82 |
17,22 |
A |
R |
|
B02BD02 |
10-0496-01 |
Human Coagulation Factor VIII 500 IU | Baltijas Terapeitiskais Serviss | pulveris un šķīdinātājs injekciju šķīduma pagatavo-šanai |
500SV/ 5ml |
1 |
56,69 |
68,25 |
68,25 |
51,19 |
34,13 |
A |
R |
|
|
B02BD02 |
10-0497-01 |
Human Coagulation Factor VIII 1000 IU | Baltijas Terapeitiskais Serviss | pulveris un šķīdinātājs injekciju šķīduma pagatavo-šanai |
1000SV/ 10ml |
1 |
117,62 |
136,49 |
136,49 |
102,37 |
68,25 |
A |
R |
|
Veselības ekonomikas centra direktore D.Behmane
2.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
Kompensējamo zāļu sarakstā iekļautās medicīniskās ierīces
|
Medicīniskā ierīce |
Identifikācijas Nr. |
Medicīniskās ierīces nosaukums |
Iesniedzējs |
Iepako-juma |
Kompen-sācijas bāzes cena (Ls) |
Aptiekas cena ar 12% PVN (Ls) |
Kompensācijas summa (Ls) |
Saraksta kategorija |
Pazīme |
||
|
100% |
75% |
50% |
|||||||||
| Inkontinences līdzekļi |
11/02-064/15-01 |
Hartmann Molicare Mobile Super S | Magnum Medical SIA |
14 |
5,32 |
7,30 |
7,30 |
5,48 |
3,65 |
A |
R |
|
11/02-065/15-01 |
Hartmann Molicare Mobile Super M | Magnum Medical SIA |
14 |
5,71 |
7,81 |
7,81 |
5,86 |
3,91 |
A |
R |
|
|
11/02-066/15-01 |
Hartmann Molicare Mobile Super L | Magnum Medical SIA |
14 |
7,21 |
9,73 |
9,73 |
7,30 |
4,87 |
A |
R |
|
|
11/02-001/07-01 |
ABENA Delta Form M1 | NCare SIA |
20 |
3,95 |
5,51 |
5,51 |
4,13 |
2,76 |
A |
R |
|
|
11/02-002/07-01 |
ABENA Delta Form M2 | NCare SIA |
20 |
4,79 |
6,61 |
6,28 |
4,71 |
3,14 |
A |
|
|
|
11/02-003/07-01 |
ABENA Delta Form L1 | NCare SIA |
20 |
4,88 |
6,73 |
6,73 |
5,05 |
3,37 |
A |
R |
|
|
11/02-004/07-01 |
ABENA Delta Form L2 | NCare SIA |
20 |
5,50 |
7,54 |
7,54 |
5,66 |
3,77 |
A |
R |
|
|
11/02-067/15-01 |
Hartmann Molicare Super Premium S | Magnum Medical SIA |
28 |
5,63 |
7,69 |
7,69 |
5,77 |
3,85 |
A |
R |
|
|
11/02-068/15-01 |
Hartmann Molicare Super Premium M | Magnum Medical SIA |
28 |
6,48 |
8,79 |
8,79 |
6,59 |
4,40 |
A |
R |
|
|
11/02-069/15-01 |
Hartmann Molicare Super Premium L | Magnum Medical SIA |
28 |
7,88 |
10,60 |
10,56 |
7,92 |
5,28 |
A |
|
|
Veselības ekonomikas centra direktore D.Behmane
3.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
Kompensācijas bāzes cenas un/vai references cenas maiņa Kompensējamo zāļu saraksta zālēm
|
Zāļu vispārīgais nosaukums |
ATC kodi |
Medikamenta identifikācijas Nr. |
Zāļu nosaukums |
Reģistrācijas apliecības īpašnieks |
Forma |
Stiprums mg |
Iepakojuma lielums |
Kompensācijas bāzes cena (Ls) |
Aptie-kas cena ar PVN |
Kompensācijas summa (Ls) |
Saraksta kategorija |
Medikamenta pazīme |
||
|
100% |
75% |
50% |
||||||||||||
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
| Acidum ibandronicum |
M05BA06 |
10-0149-01 |
Ossica 150mg | Gedeon Richter Plc. | apvalkota tablete |
150 |
1 |
11,50 |
15,18 |
9,92 |
7,44 |
4,96 |
A |
|
|
M05BA06 |
EU/1/03/265/003 |
Bonviva | Roche Registration Limited | apvalkota tablete |
150 |
1 |
16,05 |
20,74 |
9,92 |
7,44 |
4,96 |
A |
|
|
|
M05BA06 |
EU/1/03/265/004 |
Bonviva | Roche Registration Limited | apvalkotas tabletes |
150 |
3 |
40,85 |
50,00 |
30,20 |
22,65 |
15,10 |
A |
|
|
|
M05BA06 |
EU/1/03/265/005 |
Bonviva | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
3mg/3ml |
1 |
49,65 |
60,35 |
30,20 |
22,65 |
15,10 |
A |
|
|
| Acidum mycophenolicum |
L04AA06 |
05-0270-03 |
Myfortic 360mg | Novartis Finland Oy | zarnās šķīstošas tabletes |
360 |
120 |
199,79 |
228,52 |
135,84 |
101,88 |
67,92 |
A |
|
|
L04AA06 |
EU/1/07/438/003 |
Myfenax | Teva Pharma B.V. | apvalkotas tabletes |
500 |
50 |
46,48 |
56,62 |
56,62 |
42,47 |
28,31 |
A |
R |
|
|
L04AA06 |
EU/1/96/005/002 |
CellCept | Roche Registration Limited | tabletes |
500 |
50 |
52,42 |
63,47 |
56,62 |
42,47 |
28,31 |
A |
|
|
| Acidum zoledronicum |
M05BA08 |
EU/1/05/308/001 |
Aclasta | Novartis Europharm Limited | šķīdums infūzijām |
5mg/ 100ml |
1 |
230,20 |
262,58 |
120,82 |
90,62 |
60,41 |
A |
|
| Alfuzosinum |
G04CA01 |
07-0219-02 |
Alfuzosin-Teva 10mg | Teva Pharma B.V. | ilgstošas darbības tabletes |
10 |
30 |
8,79 |
11,77 |
11,77 |
8,83 |
5,89 |
A |
R |
|
G04CA01 |
99-0702-01 |
Xatral SR 10mg | Sanofi-aventis Latvia SIA | ilgstošas darbības tabletes |
10 |
30 |
10,89 |
14,43 |
11,77 |
8,83 |
5,89 |
A |
|
|
| Amlodipinum/ Valsartanum |
C09DB01 |
EU/1/06/370/011 |
Exforge | Novartis Europharm Limited | apvalkotas tabletes |
5/160 |
28 |
17,34 |
22,29 |
7,94 |
5,96 |
3,97 |
A |
|
|
C09DB01 |
EU/1/06/370/019 |
Exforge | Novartis Europharm Limited | apvalkotas tabletes |
10/160 |
28 |
18,52 |
23,71 |
9,06 |
6,80 |
4,53 |
A |
|
|
| Anastrozolum |
L02BG03 |
07-0288-05 |
Anastrozole Actavis 1mg | Actavis Group PCT ehf | apvalkotas tabletes |
1 |
28 |
21,25 |
26,95 |
26,95 |
20,21 |
13,48 |
A |
R |
|
L02BG03 |
07-0287-05 |
Anastrozole-Teva 1mg | Teva Pharma B.V. | apvalkotas tabletes |
1 |
28 |
21,25 |
26,95 |
26,95 |
20,21 |
13,48 |
A |
R |
|
|
L02BG03 |
08-0197-02 |
Axastrol 1mg | Grindeks AS | apvalkotas tabletes |
1 |
28 |
21,25 |
26,95 |
26,95 |
20,21 |
13,48 |
A |
R |
|
|
L02BG03 |
08-0104-03 |
Mammozole 1mg | Gedeon Richter Plc. | apvalkotas tabletes |
1 |
28 |
21,25 |
26,95 |
26,95 |
20,21 |
13,48 |
A |
R |
|
|
L02BG03 |
07-0289-05 |
Anastrozole SanoSwiss 1mg | SanoSwiss UAB | apvalkotas tabletes |
1 |
28 |
22,41 |
28,31 |
26,95 |
20,21 |
13,48 |
A |
|
|
|
L02BG03 |
00-0466-01 |
Arimidex 1mg | AstraZeneca UK Limited | apvalkotas tabletes |
1 |
28 |
28,15 |
35,07 |
26,95 |
20,21 |
13,48 |
A |
|
|
|
L02BG03 |
10-0276-05 |
Zenbrest 1mg | Zentiva k.s. | apvalkotas tabletes |
1 |
30 |
22,89 |
28,87 |
28,87 |
21,65 |
14,44 |
A |
R |
|
|
L02BG03 |
08-0225-05 |
Zynzol 1mg | Lannacher Heilmittel GmbH | apvalkotas tabletes |
1 |
30 |
24,13 |
30,34 |
28,87 |
21,65 |
14,44 |
A |
|
|
| Atorvastatinum |
C10AA05 |
08-0380-07 |
Atilen 20mg | Teva Pharma B.V. | apvalkotas tabletes |
20 |
30 |
3,64 |
5,11 |
3,37 |
2,53 |
1,69 |
A |
|
|
C10AA05 |
07-0172-07 |
Lopamol 20mg | Gedeon Richter Plc. | apvalkotas tabletes |
20 |
30 |
3,64 |
5,11 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
C10AA05 |
05-0330-01 |
Torvacard 20mg | Zentiva k.s. | apvalkotas tabletes |
20 |
30 |
3,64 |
5,11 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
C10AA05 |
07-0175-07 |
Atorvastatin Polpharma 20mg | Pharmaceutical Works "Polpharma" S.A. | apvalkotas tabletes |
20 |
30 |
3,83 |
5,35 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
C10AA05 |
10-0469-04 |
Tulip 20mg | Sandoz d.d. | apvalkotas tabletes |
20 |
30 |
3,83 |
5,35 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
C10AA05 |
07-0113-07 |
Atorvastatin Actavis 20mg | Actavis Group hf | apvalkotas tabletes |
20 |
30 |
4,33 |
6,01 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
C10AA05 |
03-0363-01 |
Atoris 20mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
20 |
30 |
5,34 |
7,32 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
C10AA05 |
98-0599-01 |
Sortis 20mg | Pfizer Limited | apvalkotas tabletes |
20 |
30 |
9,69 |
12,92 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
C10AA05 |
08-0381-07 |
Atilen 40mg | Teva Pharma B.V. | apvalkotas tabletes |
40 |
30 |
6,88 |
9,31 |
6,66 |
5,00 |
3,33 |
A |
|
|
|
C10AA05 |
07-0173-07 |
Lopamol 40mg | Gedeon Richter Plc. | apvalkotas tabletes |
40 |
30 |
6,88 |
9,31 |
6,66 |
5,00 |
3,33 |
A |
|
|
|
C10AA05 |
05-0331-01 |
Torvacard 40mg | Zentiva k.s. | apvalkotas tabletes |
40 |
30 |
6,88 |
9,31 |
6,66 |
5,00 |
3,33 |
A |
|
|
|
C10AA05 |
07-0176-07 |
Atorvastatin Polpharma 40mg | Pharmaceutical Works "Polpharma" S.A. | apvalkotas tabletes |
40 |
30 |
7,39 |
9,97 |
6,66 |
5,00 |
3,33 |
A |
|
|
|
C10AA05 |
05-0169-01 |
Atoris 40mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
40 |
30 |
7,73 |
10,40 |
6,66 |
5,00 |
3,33 |
A |
|
|
|
C10AA05 |
07-0114-07 |
Atorvastatin Actavis 40mg | Actavis Group hf | apvalkotas tabletes |
40 |
30 |
7,73 |
10,40 |
6,66 |
5,00 |
3,33 |
A |
|
|
|
C10AA05 |
98-0600-01 |
Sortis 40mg | Pfizer Limited | apvalkotas tabletes |
40 |
30 |
9,69 |
12,92 |
6,66 |
5,00 |
3,33 |
A |
|
|
|
C10AA05 |
03-0502-01 |
Sortis 80mg | Pfizer Limited | apvalkotas tabletes |
80 |
30 |
20,10 |
25,60 |
13,20 |
9,90 |
6,60 |
A |
|
|
| Beclometasonum/ Formoterolum |
R03AK07 |
08-0224-01 |
Foster 100/6mcg | Torrex Chiesi Pharma GmbH | aerosols inhalācijām |
0.1/0.006 mg/devā |
120 devas |
23,72 |
29,86 |
28,57 |
21,43 |
14,29 |
A |
|
| Betahistinum |
N07CA01 |
06-0220-02 |
Betahistin Actavis 16mg | Actavis Group hf | tabletes |
16 |
60 |
3,31 |
4,67 |
4,67 |
3,50 |
2,34 |
A |
R |
|
N07CA01 |
03-0317-02 |
Betaserc 24mg | Abbott Healthcare Products B.V. | tabletes |
24 |
50 |
8,04 |
10,81 |
5,80 |
4,35 |
2,90 |
A |
|
|
|
N07CA01 |
I000108-01 |
Betaserc 24mg | ELPIS SIA (paralēlais importētājs) | tabletes |
24 |
50 |
8,04 |
10,81 |
5,80 |
4,35 |
2,90 |
A |
P |
|
|
N07CA01 |
07-0371-05 |
Polvertic 24mg | Medana Pharma SA | tabletes |
24 |
60 |
8,95 |
11,97 |
6,96 |
5,22 |
3,48 |
A |
|
|
| Bicalutamidum |
L02BB03 |
07-0110-06 |
Bicalutamid Actavis 50mg | Actavis Group PCT ehf | apvalkotas tabletes |
50 |
28 |
34,35 |
42,36 |
42,36 |
31,77 |
21,18 |
A |
R |
|
L02BB03 |
10-0042-03 |
Bicalutamide Grindeks 50mg | Grindeks AS | apvalkotas tabletes |
50 |
28 |
34,35 |
42,36 |
42,36 |
31,77 |
21,18 |
A |
R |
|
|
L02BB03 |
07-0139-02 |
Bicalutamide Teva 50mg | Teva Pharma B.V. | apvalkotas tabletes |
50 |
28 |
34,35 |
42,36 |
42,36 |
31,77 |
21,18 |
A |
R |
|
|
L02BB03 |
98-0735-01 |
Casodex 50mg | AstraZeneca UK Limited | apvalkotas tabletes |
50 |
28 |
54,88 |
66,23 |
42,36 |
31,77 |
21,18 |
A |
|
|
|
L02BB03 |
04-0314-01 |
Calumid 50mg | Gedeon Richter Plc. | apvalkotas tabletes |
50 |
30 |
36,92 |
45,38 |
45,38 |
34,04 |
22,69 |
A |
R |
|
|
L02BB03 |
07-0111-06 |
Bicalutamid Actavis 150mg | Actavis Group PCT ehf | apvalkotas tabletes |
150 |
28 |
102,33 |
119,37 |
119,37 |
89,53 |
59,69 |
A |
R |
|
|
L02BB03 |
08-0037-02 |
Bicalutamide Teva 150mg | Teva Pharma B.V. | apvalkotas tabletes |
150 |
28 |
102,33 |
119,37 |
119,37 |
89,53 |
59,69 |
A |
R |
|
|
L02BB03 |
02-0267-01 |
Casodex 150mg | AstraZeneca UK Limited | apvalkotas tabletes |
150 |
28 |
164,46 |
188,96 |
119,37 |
89,53 |
59,69 |
A |
|
|
| Bimatoprostum |
S01EE03 |
EU/1/02/205/001 |
Lumigan | Allergan Pharmaceuticals Ireland | acu pilieni, šķīdums |
0.3mg/ml-3ml |
1 gab. |
9,19 |
12,29 |
6,79 |
5,09 |
3,40 |
A |
|
| Bimatoprostum/ Timololum |
S01ED51 |
EU/1/06/340/001 |
Ganfort | Allergan Pharmaceuticals Ireland | acu pilieni, šķīdums |
0.3/5mg/ ml-3ml |
1 gab. |
10,32 |
13,72 |
7,90 |
5,93 |
3,95 |
A |
|
| Calcii folinatum |
V03AF03 |
99-0863-01 |
Leucovorin-Teva 10mg/ml | Teva Pharma B.V. | šķīdums injekcijām |
50mg/ 5ml |
1 |
2,91 |
4,08 |
4,08 |
3,06 |
2,04 |
B |
|
|
V03AF03 |
99-0864-02 |
Leucovorin-Teva 10mg/ml | Teva Pharma B.V. | šķīdums injekcijām |
100mg/ 10ml |
1 |
4,25 |
5,90 |
5,90 |
4,43 |
2,95 |
B |
|
|
| Candesartanum |
C09CA06 |
99-0118-01 |
Atacand 8mg | AstraZeneca AB | tabletes |
8 |
28 |
10,83 |
14,35 |
3,02 |
2,27 |
1,51 |
A |
|
|
C09CA06 |
99-0119-01 |
Atacand 16mg | AstraZeneca AB | tabletes |
16 |
28 |
12,95 |
16,97 |
6,02 |
4,52 |
3,01 |
A |
|
|
| Candesartanum/ Hydrochloro-thiazidum |
C09DA06 |
RN001-01 |
Atacand Plus | AstraZeneca UK Ltd | tabletes |
16/12.5 |
28 |
12,95 |
16,97 |
7,41 |
5,56 |
3,71 |
A |
|
| Carvedilolum |
C07AG02 |
04-0180-01 |
CarvedilolHexal 6,25mg | Hexal AG | tabletes |
6,25 |
30 |
1,45 |
2,08 |
2,08 |
1,56 |
1,04 |
A |
R |
|
C07AG02 |
04-0181-01 |
CarvedilolHexal 12,5mg | Hexal AG | tabletes |
12,5 |
30 |
2,22 |
3,15 |
2,88 |
2,16 |
1,44 |
A |
|
|
|
C07AG02 |
04-0182-01 |
CarvedilolHexal 25mg | Hexal AG | tabletes |
25 |
30 |
4,17 |
5,80 |
3,67 |
2,75 |
1,84 |
A |
|
|
| Ciclosporinum |
L04AD01 |
03-0351-01 |
Equoral 25mg | TEVA Czech Industries s.r.o. | mīkstas kapsulas |
25 |
50 |
14,28 |
18,60 |
18,60 |
13,95 |
9,30 |
A |
R |
|
L04AD01 |
95-0140-01 |
Sandimmun Neoral 25mg | Novartis Finland Oy | mīkstas želatīna kapsulas |
25 |
50 |
16,80 |
21,65 |
18,60 |
13,95 |
9,30 |
A |
|
|
|
L04AD01 |
03-0352-01 |
Equoral 50mg | TEVA Czech Industries s.r.o. | mīkstas kapsulas |
50 |
50 |
23,33 |
29,40 |
29,40 |
22,05 |
14,70 |
A |
R |
|
|
L04AD01 |
00-1191-01 |
Sandimmun Neoral 50mg | Novartis Finland Oy | mīkstas želatīna kapsulas |
50 |
50 |
33,28 |
41,09 |
29,40 |
22,05 |
14,70 |
A |
|
|
|
L04AD01 |
03-0353-01 |
Equoral 100mg | TEVA Czech Industries s.r.o. | mīkstas kapsulas |
100 |
50 |
46,67 |
56,84 |
56,84 |
42,63 |
28,42 |
A |
R |
|
|
L04AD01 |
00-1192-01 |
Sandimmun Neoral 100mg | Novartis Finland Oy | mīkstas želatīna kapsulas |
100 |
50 |
66,56 |
79,31 |
56,84 |
42,63 |
28,42 |
A |
|
|
| Cinacalcetum |
H05BX01 |
EU/1/04/292/002 |
Mimpara | Amgen Europe B.V. | apvalkotas tabletes |
30 |
28 |
122,78 |
142,27 |
142,27 |
106,70 |
71,14 |
B |
|
|
H05BX01 |
EU/1/04/292/006 |
Mimpara | Amgen Europe B.V. | apvalkotas tabletes |
60 |
28 |
229,43 |
261,72 |
261,72 |
196,29 |
130,86 |
B |
|
|
|
H05BX01 |
EU/1/04/292/010 |
Mimpara | Amgen Europe B.V. | apvalkotas tabletes |
90 |
28 |
328,56 |
372,75 |
372,75 |
279,56 |
186,38 |
B |
|
|
| Clarithromycinum |
J01FA09 |
94-0307-03 |
Klacid 250mg | Abbott Laboratories Baltics SIA | apvalkotas tabletes |
250 |
10 |
4,92 |
6,79 |
4,44 |
3,33 |
2,22 |
A |
|
|
J01FA09 |
02-0053-02 |
Klabax 250mg | Ranbaxy UK Ltd | apvalkotas tabletes |
250 |
14 |
5,39 |
7,39 |
6,22 |
4,67 |
3,11 |
A |
|
|
|
J01FA09 |
98-0771-01 |
Fromilid 250mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
250 |
14 |
6,20 |
8,43 |
6,22 |
4,67 |
3,11 |
A |
|
|
|
J01FA09 |
02-0054-02 |
Klabax 500mg | Ranbaxy UK Ltd | apvalkotas tabletes |
500 |
14 |
8,49 |
11,38 |
9,99 |
7,49 |
5,00 |
A |
|
|
|
J01FA09 |
02-0377-02 |
Klerimed 500mg | Medochemie Ltd. | apvalkotas tabletes |
500 |
14 |
8,52 |
11,42 |
9,99 |
7,49 |
5,00 |
A |
|
|
|
J01FA09 |
98-0772-01 |
Fromilid 500mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
500 |
14 |
10,08 |
13,43 |
9,99 |
7,49 |
5,00 |
A |
|
|
| Clonazepamum |
N03AE01 |
96-0159-01 |
Clonazepam 2mg | Tarchomin Pharmaceutical Works "Polfa" S.A. | tabletes |
2 |
30 |
1,34 |
1,94 |
1,61 |
1,21 |
0,81 |
A |
|
| Clopidogrelum |
B01AC04 |
10-0409-16 |
Clopidogrel GSK 75mg | GlaxoSmithKline Latvia SIA | apvalkotas tabletes |
75 |
28 |
5,92 |
8,08 |
8,08 |
6,06 |
4,04 |
A |
R |
|
B01AC04 |
09-0466-02 |
Clopidogrel Portfarma 75mg | Portfarma ehf | apvalkotas tabletes |
75 |
28 |
5,92 |
8,08 |
8,08 |
6,06 |
4,04 |
A |
R |
|
|
B01AC04 |
EU/1/09/540/002 |
Clopidogrel Teva | Teva Pharma B.V. | apvalkotas tabletes |
75 |
28 |
5,92 |
8,08 |
8,08 |
6,06 |
4,04 |
A |
R |
|
|
B01AC04 |
10-0098-02 |
Nofardom 75mg | Norameda UAB | apvalkotas tabletes |
75 |
28 |
5,92 |
8,08 |
8,08 |
6,06 |
4,04 |
A |
R |
|
|
B01AC04 |
09-0371-05 |
Clopimef 75mg | Mepha-Investigacao, Desenvolvimento e Fabricacao Farmaceutica | apvalkotas tabletes |
75 |
28 |
5,96 |
8,12 |
8,08 |
6,06 |
4,04 |
A |
|
|
|
B01AC04 |
09-0443-02 |
Plavocorin 75mg | Sandoz d.d. | apvalkotas tabletes |
75 |
28 |
6,32 |
8,59 |
8,08 |
6,06 |
4,04 |
A |
|
|
|
B01AC04 |
10-0166-05 |
Clopidogrel SanoSwiss 75mg | SanoSwiss UAB | apvalkotas tabletes |
75 |
28 |
6,48 |
8,79 |
8,08 |
6,06 |
4,04 |
A |
|
|
|
B01AC04 |
10-0103-01 |
Clopigamma 75mg | Worwag Pharma GmbH & Co.KG | apvalkotas tabletes |
75 |
28 |
6,48 |
8,79 |
8,08 |
6,06 |
4,04 |
A |
|
|
|
B01AC04 |
EU/1/09/553/003 |
Zyllt | KRKA d.d., Novo Mesto | apvalkotas tabletes |
75 |
28 |
8,34 |
11,19 |
8,08 |
6,06 |
4,04 |
A |
|
|
|
B01AC04 |
EU/1/98/069/001a |
Plavix | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
75 |
28 |
9,68 |
12,91 |
8,08 |
6,06 |
4,04 |
A |
|
|
|
B01AC04 |
09-0387-01 |
Egitromb 75mg | Egis Pharmaceuticals PLC | apvalkotas tabletes |
75 |
28 |
10,03 |
13,36 |
8,08 |
6,06 |
4,04 |
A |
|
|
|
B01AC04 |
09-0257-01 |
Trombex 75mg | Zentiva k.s. | apvalkotas tabletes |
75 |
30 |
6,37 |
8,66 |
8,66 |
6,50 |
4,33 |
A |
R |
|
|
B01AC04 |
EU/1/09/553/006 |
Zyllt | KRKA d.d., Novo Mesto | apvalkotas tabletes |
75 |
56 |
14,93 |
19,40 |
16,13 |
12,10 |
8,07 |
A |
|
|
|
B01AC04 |
09-0371-10 |
Clopimef 75mg | Mepha-Investigacao, Desenvolvimento e Fabricacao Farmaceutica | apvalkotas tabletes |
75 |
84 |
17,57 |
22,57 |
22,57 |
16,93 |
11,29 |
A |
R |
|
|
B01AC04 |
EU/1/98/069/003a |
Plavix | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
75 |
84 |
28,51 |
35,49 |
22,57 |
16,93 |
11,29 |
A |
|
|
|
B01AC04 |
09-0257-02 |
Trombex 75mg | Zentiva k.s. | apvalkotas tabletes |
75 |
90 |
18,92 |
24,18 |
24,18 |
18,14 |
12,09 |
A |
R |
|
| Clopidogrelum/ Acidum acetylsalicylicum |
B01AC30 |
EU/1/10/619/009 |
DuoPlavin | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
75/100 |
28 |
9,68 |
12,91 |
8,08 |
6,06 |
4,04 |
A |
|
| Cyproteronum |
G03HA01 |
95-0266-03 |
Androcur 50mg | Bayer Schering Pharma AG | tabletes |
50 |
50 |
20,30 |
25,84 |
25,84 |
19,38 |
12,92 |
A |
R |
|
G03HA01 |
00-0838-01 |
Cyproplex 50mg | Teva Pharma B.V. | tabletes |
50 |
50 |
20,30 |
25,84 |
25,84 |
19,38 |
12,92 |
A |
R |
|
| Darbepoetinum alfa |
B03XA02 |
EU/1/01/185/007 |
Aranesp | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.03mg/ 0.3ml |
1 |
36,28 |
44,62 |
40,35 |
30,26 |
20,18 |
A |
|
|
B03XA02 |
EU/1/01/185/009 |
Aranesp | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.04mg/ 0.4ml |
1 |
48,82 |
59,37 |
53,64 |
40,23 |
26,82 |
A |
|
|
|
B03XA02 |
EU/1/01/185/011 |
Aranesp | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.05mg/ 0.5ml |
1 |
62,00 |
74,20 |
67,03 |
50,27 |
33,52 |
A |
|
|
|
B03XA02 |
EU/1/01/185/013 |
Aranesp | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.06mg/ 0.3ml |
1 |
72,99 |
86,51 |
78,33 |
58,75 |
39,17 |
A |
|
|
|
B03XA02 |
EU/1/01/185/015 |
Aranesp | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.08mg/ 0.4ml |
1 |
97,16 |
113,58 |
102,69 |
77,02 |
51,35 |
A |
|
|
|
B03XA02 |
EU/1/01/185/017 |
Aranesp | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.1mg/ 0.5ml |
1 |
121,32 |
140,64 |
127,05 |
95,29 |
63,53 |
A |
|
|
|
B03XA02 |
EU/1/01/185/019 |
Aranesp | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.15mg/ 0.3ml |
1 |
180,89 |
207,36 |
187,10 |
140,33 |
93,55 |
A |
|
|
| Diazepamum |
N05BA01 |
96-0160-01 |
Relium 5mg | Tarchomin Pharmaceutical Works "Polfa" S.A. | apvalkotas tabletes |
5 |
20 |
0,28 |
0,40 |
0,35 |
0,26 |
0,18 |
A |
|
| Didanosinum |
J05AF02 |
05-0228-01 |
Videx EC 400mg | Bristol-Myers Squibb | zarnās šķīstošas cietas kapsulas |
400 |
30 |
111,76 |
129,93 |
129,93 |
97,45 |
64,97 |
B |
|
| Dorzolamidum |
S01EC03 |
98-0168-01 |
Trusopt 20mg/ml | SIA "Merck Sharp & Dohme Latvija" | acu pilieni, šķīdums |
20mg/ml-5ml |
1 gab. |
5,86 |
8,00 |
6,55 |
4,91 |
3,28 |
A |
|
| Dorzolamidum/ Timololum |
S01ED51 |
99-0966-02 |
Cosopt 20mg/5mg/ml | SIA "Merck Sharp & Dohme Latvija" | acu pilieni, šķīdums |
20/5mg/ ml-5ml |
1 gab. |
8,90 |
11,92 |
7,64 |
5,73 |
3,82 |
A |
|
|
S01ED51 |
99-0966-01 |
Cosopt 20mg/5mg/ml | SIA "Merck Sharp & Dohme Latvija" | acu pilieni, šķīdums |
20/5mg/ ml-5ml |
3 gab. |
26,21 |
32,78 |
22,85 |
17,14 |
11,43 |
A |
|
|
| Doxorubicinum |
L01DB01 |
04-0119-01 |
Adriblastina PFS 10mg/5ml | Pfizer Italia s.r.l. | šķīdums injekcijām |
10mg/5ml |
1 |
2,93 |
4,11 |
3,92 |
2,94 |
1,96 |
A |
|
|
L01DB01 |
95-0068-01 |
Doxorubicin "Ebewe" 10mg/5ml | Ebewe Pharma GmbH, Nfg.KG | koncentrāts infūziju šķīduma pagatavo-šanai |
10mg/ 5ml |
1 |
2,93 |
4,11 |
3,92 |
2,94 |
1,96 |
A |
|
|
|
L01DB01 |
99-0773-01 |
Doxorubicin-Teva 10mg | Teva Pharma B.V. | pulveris injekciju šķīduma pagatavo-šanai |
10 |
1 |
2,93 |
4,11 |
3,92 |
2,94 |
1,96 |
A |
|
|
|
L01DB01 |
04-0120-01 |
Adriblastina PFS 50mg/25ml | Pfizer Italia s.r.l. | šķīdums injekcijām |
50mg/ 25ml |
1 |
15,83 |
20,48 |
19,59 |
14,69 |
9,80 |
A |
|
|
|
L01DB01 |
95-0067-01 |
Doxorubicin "Ebewe" 50mg/25ml | Ebewe Pharma GmbH, Nfg.KG | koncentrāts infūziju šķīduma pagatavo-šanai |
50mg/ 25ml |
1 |
15,83 |
20,48 |
19,59 |
14,69 |
9,80 |
A |
|
|
|
L01DB01 |
99-0774-01 |
Doxorubicin-Teva 50mg | Teva Pharma B.V. | pulveris injekciju šķīduma pagatavo-šanai |
50 |
1 |
15,83 |
20,48 |
19,59 |
14,69 |
9,80 |
A |
|
|
| Dutasteridum |
G04CB02 |
04-0410-01 |
Avodart 0,5mg | Glaxo Group Ltd. | mīkstas kapsulas |
0,5 |
30 |
14,40 |
18,72 |
18,72 |
14,04 |
9,36 |
B |
|
| Eprosartanum |
C09CA02 |
01-0436-02 |
Teveten 600mg | Abbott Healthcare Products B.V. | apvalkotas tabletes |
600 |
28 |
13,50 |
17,64 |
3,02 |
2,27 |
1,51 |
A |
|
| Erythropoietinum |
B03XA01 |
02-0253-01 |
Eprex 2000IU/0,5ml | UAB Johnson & Johnson | šķīdums injekcijām pilnšļircēs |
2 000SV/ 0.5ml |
6 |
50,15 |
60,93 |
60,93 |
45,70 |
30,47 |
A |
R |
|
B03XA01 |
EU/1/97/031/030 |
NeoRecormon | Roche Registration Limited | šķīdums injekcijām pilnšļircēs |
2 000SV/ 0.3ml |
6 |
71,64 |
85,00 |
60,93 |
45,70 |
30,47 |
A |
|
|
|
B03XA01 |
02-0254-01 |
Eprex 4000IU/0,4ml | UAB Johnson & Johnson | šķīdums injekcijām pilnšļircēs |
4 000SV/ 0.4ml |
6 |
99,31 |
115,99 |
115,99 |
86,99 |
58,00 |
A |
R |
|
|
B03XA01 |
EU/1/97/031/042 |
NeoRecormon | Roche Registration Limited | šķīdums injekcijām pilnšļircēs |
4 000SV/ 0.3ml |
6 |
141,88 |
163,67 |
115,99 |
86,99 |
58,00 |
A |
|
|
|
B03XA01 |
01-0405-01 |
Eprex 6000IU/0,6ml | UAB Johnson & Johnson | šķīdums injekcijām pilnšļircēs |
6 000SV/ 0.6ml |
6 |
146,94 |
169,33 |
169,33 |
127,00 |
84,67 |
A |
R |
|
|
B03XA01 |
EU/1/97/031/044 |
NeoRecormon | Roche Registration Limited | šķīdums injekcijām pilnšļircēs |
6 000SV/ 0.3ml |
6 |
209,92 |
239,87 |
169,33 |
127,00 |
84,67 |
A |
|
|
|
B03XA01 |
02-0255-01 |
Eprex 10 000IU/ml |
UAB Johnson & Johnson | šķīdums injekcijām pilnšļircēs |
10 000SV/ ml |
6 |
228,02 |
260,14 |
260,14 |
195,11 |
130,07 |
A |
R |
|
|
B03XA01 |
EU/1/97/031/036 |
NeoRecormon | Roche Registration Limited | šķīdums injekcijām pilnšļircēs |
10 000SV/ 0.6ml |
6 |
325,75 |
369,60 |
260,14 |
195,11 |
130,07 |
A |
|
|
| Escitalopramum |
N06AB10 |
07-0297-03 |
Cipralex 5mg | H. Lundbeck A/S | apvalkotas tabletes |
5 |
28 |
6,33 |
8,60 |
2,95 |
2,21 |
1,48 |
A |
|
|
N06AB10 |
09-0417-06 |
Escitil 10mg | Egis Pharmaceuticals PLC | apvalkotas tabletes |
10 |
28 |
4,24 |
5,89 |
5,89 |
4,42 |
2,95 |
A |
R |
|
|
N06AB10 |
09-0171-04 |
Escitalopram-Teva 10mg | Teva Pharma B.V. | apvalkotas tabletes |
10 |
28 |
5,17 |
7,11 |
5,89 |
4,42 |
2,95 |
A |
|
|
|
N06AB10 |
09-0263-02 |
Nepanil 10mg | Gedeon Richter Plc. | apvalkotas tabletes |
10 |
28 |
5,17 |
7,11 |
5,89 |
4,42 |
2,95 |
A |
|
|
|
N06AB10 |
09-0377-02 |
Elicea 10mg | KRKA d.d., Novo mesto | apvalkotas tabletes |
10 |
28 |
5,44 |
7,46 |
5,89 |
4,42 |
2,95 |
A |
|
|
|
N06AB10 |
07-0298-03 |
Cipralex 10mg | H. Lundbeck A/S | apvalkotas tabletes |
10 |
28 |
11,44 |
15,10 |
5,89 |
4,42 |
2,95 |
A |
|
|
|
N06AB10 |
09-0421-01 |
Eslorex 10mg | Zentiva k.s. | apvalkotas tabletes |
10 |
30 |
5,86 |
8,00 |
6,29 |
4,72 |
3,15 |
A |
|
|
|
N06AB10 |
07-0299-03 |
Cipralex 15mg | H. Lundbeck A/S | apvalkotas tabletes |
15 |
28 |
16,70 |
21,53 |
8,78 |
6,59 |
4,39 |
A |
|
|
|
N06AB10 |
09-0173-04 |
Escitalopram-Teva 20mg | Teva Pharma B.V. | apvalkotas tabletes |
20 |
28 |
10,22 |
13,60 |
11,68 |
8,76 |
5,84 |
A |
|
|
|
N06AB10 |
09-0378-02 |
Elicea 20mg | KRKA d.d., Novo mesto | apvalkotas tabletes |
20 |
28 |
11,22 |
14,83 |
11,68 |
8,76 |
5,84 |
A |
|
|
|
N06AB10 |
09-0435-04 |
Escitalopram-ratiopharm 20mg | Ratiopharm GmbH | apvalkotas tabletes |
20 |
30 |
10,99 |
14,55 |
12,52 |
9,39 |
6,26 |
A |
|
|
| Exemestanum |
L02BG06 |
10-0238-03 |
Exemestane Teva 25mg | Teva Pharma B.V. | apvalkotas tabletes |
25 |
30 |
44,46 |
54,24 |
54,24 |
40,68 |
27,12 |
A |
R |
|
L02BG06 |
02-0063-03 |
Aromasin 25mg | Pfizer Italia s.r.l. | apvalkotas tabletes |
25 |
30 |
72,07 |
85,48 |
54,24 |
40,68 |
27,12 |
A |
|
|
|
L02BG06 |
02-0063-04 |
Aromasin 25mg | Pfizer Italia s.r.l. | apvalkotas tabletes |
25 |
90 |
214,14 |
244,60 |
162,63 |
121,97 |
81,32 |
A |
|
|
| Fentanylum |
N02AB03 |
07-0379-01 |
Dolforin 25mcg/h | Gedeon Richter Plc. | transdermāli plāksteri |
0.025mg/h |
5 |
9,82 |
13,09 |
13,09 |
9,82 |
6,55 |
A |
R |
|
N02AB03 |
99-0954-02 |
Durogesic 25mcg/h | UAB Johnson & Johnson | transdermāli plāksteri |
0.025mg/h |
5 |
9,82 |
13,09 |
13,09 |
9,82 |
6,55 |
A |
R |
|
|
N02AB03 |
06-0205-01 |
Matrifen 25mcg/h | Nycomed SEFA AS | transdermāli plāksteri |
0.025mg/h |
5 |
9,82 |
13,09 |
13,09 |
9,82 |
6,55 |
A |
R |
|
|
N02AB03 |
07-0380-01 |
Dolforin 50mcg/h | Gedeon Richter Plc. | transdermāli plāksteri |
0.05mg/h |
5 |
18,55 |
23,74 |
23,74 |
17,81 |
11,87 |
A |
R |
|
|
N02AB03 |
99-0955-02 |
Durogesic 50mcg/h | UAB Johnson & Johnson | transdermāli plāksteri |
0.05mg/h |
5 |
18,55 |
23,74 |
23,74 |
17,81 |
11,87 |
A |
R |
|
|
N02AB03 |
06-0206-01 |
Matrifen 50mcg/h | Nycomed SEFA AS | transdermāli plāksteri |
0.05mg/h |
5 |
18,55 |
23,74 |
23,74 |
17,81 |
11,87 |
A |
R |
|
|
N02AB03 |
07-0381-01 |
Dolforin 75mcg/h | Gedeon Richter Plc. | transdermāli plāksteri |
0.075mg/h |
5 |
26,50 |
33,13 |
33,13 |
24,85 |
16,57 |
A |
R |
|
|
N02AB03 |
99-0956-02 |
Durogesic 75mcg/h | UAB Johnson & Johnson | transdermāli plāksteri |
0.075mg/h |
5 |
26,50 |
33,13 |
33,13 |
24,85 |
16,57 |
A |
R |
|
|
N02AB03 |
06-0207-01 |
Matrifen 75mcg/h | Nycomed SEFA AS | transdermāli plāksteri |
0.075mg/h |
5 |
26,50 |
33,13 |
33,13 |
24,85 |
16,57 |
A |
R |
|
|
N02AB03 |
07-0382-01 |
Dolforin 100mcg/h | Gedeon Richter Plc. | transdermāli plāksteri |
0.1mg/h |
5 |
32,42 |
40,08 |
40,08 |
30,06 |
20,04 |
A |
R |
|
|
N02AB03 |
99-0957-02 |
Durogesic 100mcg/h | UAB Johnson & Johnson | transdermāli plāksteri |
0.1mg/h |
5 |
32,42 |
40,08 |
40,08 |
30,06 |
20,04 |
A |
R |
|
|
N02AB03 |
06-0208-01 |
Matrifen 100mcg/h | Nycomed SEFA AS | transdermāli plāksteri |
0.1mg/h |
5 |
32,42 |
40,08 |
40,08 |
30,06 |
20,04 |
A |
R |
|
| Filgrastimum |
L03AA02 |
EU/1/08/445/001 |
Tevagrastim | Teva Generics GmbH | šķīdums injekcijām vai infūzijām |
0.3mg/ 0.5ml |
1 |
40,20 |
49,24 |
49,24 |
36,93 |
24,62 |
A |
R |
|
L03AA02 |
05-0566-01 |
Neupogen 300mcg (0,6mg/ml) | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.3mg/ 0.5ml |
1 |
44,34 |
54,11 |
49,24 |
36,93 |
24,62 |
A |
|
|
|
L03AA02 |
EU/1/08/445/005 |
Tevagrastim | Teva Generics GmbH | šķīdums injekcijām vai infūzijām |
0.48mg/ 0.8ml |
1 |
64,29 |
76,76 |
76,76 |
57,57 |
38,38 |
A |
R |
|
|
L03AA02 |
05-0567-01 |
Neupogen 480mcg (0,96mg/ml) | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
0.48mg/ 0.5ml |
1 |
71,88 |
85,27 |
76,76 |
57,57 |
38,38 |
A |
|
|
| Finasteridum |
G04CB01 |
09-0454-03 |
Finasteride Portfarma 5mg | Portfarma ehf | apvalkotas tabletes |
5 |
28 |
5,46 |
7,48 |
7,48 |
5,61 |
3,74 |
A |
R |
|
G04CB01 |
06-0270-01 |
Finasterid Actavis 5mg | Actavis Group hf | apvalkotas tabletes |
5 |
30 |
5,85 |
7,99 |
7,99 |
5,99 |
4,00 |
A |
R |
|
|
G04CB01 |
99-0984-04 |
Prostarinol 5mg | Olainfarm A/S | apvalkotas tabletes |
5 |
30 |
5,99 |
8,16 |
7,99 |
5,99 |
4,00 |
A |
|
|
|
G04CB01 |
08-0287-05 |
Finasteride Teva 5mg | Teva Pharma B.V. | apvalkotas tabletes |
5 |
30 |
6,10 |
8,31 |
7,99 |
5,99 |
4,00 |
A |
|
|
|
G04CB01 |
06-0254-05 |
Finster 5mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
5 |
30 |
6,31 |
8,58 |
7,99 |
5,99 |
4,00 |
A |
|
|
|
G04CB01 |
07-0101-06 |
Androfin 5mg | G.L. Pharma GmbH | apvalkotas tabletes |
5 |
30 |
6,31 |
8,58 |
7,99 |
5,99 |
4,00 |
A |
|
|
|
G04CB01 |
04-0150-01 |
Penester 5mg | Zentiva k.s. | apvalkotas tabletes |
5 |
30 |
7,35 |
9,91 |
7,99 |
5,99 |
4,00 |
A |
|
|
| Gabapentinum |
N03AX12 |
04-0104-01 |
Gordius 300mg | Gedeon Richter Plc. | cietas kapsulas |
300 |
50 |
7,52 |
10,14 |
10,14 |
7,61 |
5,07 |
A |
R |
|
N03AX12 |
04-0105-01 |
Gordius 400mg | Gedeon Richter Plc. | cietas kapsulas |
400 |
50 |
10,14 |
13,50 |
13,50 |
10,13 |
6,75 |
A |
R |
|
| Glatirameri acetatum |
L03AX13 |
06-0274-01 |
Copaxone 20mg/ml | Teva Pharmaceutical Ltd. | šķīdums injekcijām pilnšļircēs |
20mg/ml |
28 |
512,63 |
578,91 |
578,91 |
434,18 |
289,46 |
B |
|
| Gliclazidum |
A10BB09 |
08-0047-07 |
Gliclada 30mg | KRKA d.d., Novo Mesto | ilgstošas darbības tabletes |
30 |
60 |
3,73 |
5,22 |
4,97 |
3,73 |
2,49 |
A |
|
|
A10BB09 |
08-0047-11 |
Gliclada 30mg | KRKA d.d., Novo Mesto | ilgstošas darbības tabletes |
30 |
120 |
7,75 |
10,43 |
9,92 |
7,44 |
4,96 |
A |
|
|
|
A10BB09 |
09-0536-09 |
Diaprel MR 60mg | Les Laboratoires Servier | ilgstošas darbības tabletes |
60 |
60 |
8,74 |
11,70 |
9,92 |
7,44 |
4,96 |
A |
|
|
| Granisetronum |
A04AA02 |
08-0124-02 |
Granisetron Teva 1mg/ml | Teva Pharma B.V. | koncentrāts injekciju vai infūziju šķīduma pagatavošanai |
1mg/ml |
5 |
16,26 |
21,00 |
21,00 |
15,75 |
10,50 |
A |
R |
|
A04AA02 |
01-0325-02 |
Kytril 1mg/ml | Roche Latvija SIA | šķīdums injekcijām |
1mg/ml |
5 |
25,65 |
32,12 |
21,00 |
15,75 |
10,50 |
A |
|
|
| Indapamidum |
C03BA11 |
09-0117-05 |
Indapamide Actavis 1,5mg | Actavis Group PCT ehf | ilgstošas darbības tabletes |
1,5 |
30 |
2,57 |
3,62 |
3,39 |
2,54 |
1,70 |
A |
|
|
C03BA11 |
09-0057-01 |
Indapamide Orion 1,5mg | Orion Corporation | ilgstošas darbības tabletes |
1,5 |
30 |
2,57 |
3,62 |
3,39 |
2,54 |
1,70 |
A |
|
|
|
C03BA11 |
08-0313-03 |
Indapen SR 1,5mg | J&P Pharma UK.Ltd. | ilgstošas darbības apvalkotas tabletes |
1,5 |
30 |
2,57 |
3,62 |
3,39 |
2,54 |
1,70 |
A |
|
|
|
C03BA11 |
05-0457-02 |
Rawel SR 1,5mg | KRKA d.d., Novo Mesto | ilgstošas darbības apvalkotas tabletes |
1,5 |
30 |
2,57 |
3,62 |
3,39 |
2,54 |
1,70 |
A |
|
|
|
C03BA11 |
05-0157-01 |
Tertensif SR 1,5mg | Les Laboratoires Servier | ilgstošas darbības apvalkotas tabletes |
1,5 |
30 |
3,41 |
4,80 |
3,39 |
2,54 |
1,70 |
A |
|
|
| Interferonum alfa-2a |
L03AB04 |
05-0211-01 |
Roferon-A 3 MIU | Roche Latvija SIA | šķīdums injekcijām pilnšļircē |
3mlj SV/0.5ml |
1 |
10,94 |
14,48 |
14,48 |
10,86 |
7,24 |
B |
|
| Interferonum beta-1a |
L03AB07 |
EU/1/98/063/006 |
Rebif | Serono Europe Ltd | šķīdums injekcijām pilnšļircēs |
0,044 |
12 |
621,44 |
700,77 |
700,77 |
525,58 |
350,39 |
B |
|
| Interferonum beta-1b |
L03AB08 |
EU/1/95/003/005 |
Betaferon | Bayer Schering Pharma AG | pulveris injekcijām ar šķīdinātāju |
0.25mg/ ml |
15 |
518,49 |
585,47 |
585,47 |
439,10 |
292,74 |
A |
R |
|
L03AB08 |
EU/1/08/454/002 |
Extavia | Novartis Europharm Limited | pulveris injekcijām ar šķīdinātāju |
0.25mg/ ml |
15 |
518,49 |
585,47 |
585,47 |
439,10 |
292,74 |
A |
R |
|
| Irbesartanum |
C09CA04 |
EU/1/97/046/022 |
Aprovel | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
150 |
28 |
10,43 |
13,85 |
3,02 |
2,27 |
1,51 |
A |
|
|
C09CA04 |
EU/1/97/046/027 |
Aprovel | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
300 |
28 |
13,63 |
17,80 |
6,02 |
4,52 |
3,01 |
A |
|
|
| Irbesartanum/ Hydrochloro-thiazidum |
C09DA04 |
EU/1/98/086/012 |
CoAprovel | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
150/12.5 |
28 |
10,43 |
13,85 |
3,29 |
2,47 |
1,65 |
A |
|
|
C09DA04 |
EU/1/98/086/017 |
CoAprovel | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
300/12.5 |
28 |
13,63 |
17,80 |
7,41 |
5,56 |
3,71 |
A |
|
|
|
C09DA04 |
EU/1/98/086/024 |
CoAprovel | Sanofi Pharma Bristol-Myers Squibb SCN | apvalkotas tabletes |
300/25 |
28 |
13,63 |
17,80 |
7,69 |
5,77 |
3,85 |
A |
|
|
| Isosorbidi mononitratum |
C01DA14 |
03-0479-03 |
Isomonit 60mg | Hexal AG | ilgstošas darbības tabletes |
60 |
60 |
6,41 |
8,70 |
8,19 |
6,14 |
4,10 |
A |
|
| Lanreotidum |
H01CB03 |
00-1008-01 |
Somatuline P.R. 30mg | Ipsen Pharma | pulveris un šķīdinātājs injekciju suspensijas pagatavo-šanai |
30 |
1 |
276,80 |
314,78 |
314,78 |
236,09 |
157,39 |
B |
|
|
H01CB03 |
03-0243-01 |
Somatuline Autogel 120mg | Ipsen Pharma | šķīdums injekcijām pilnšļircē |
120 |
1 |
861,60 |
969,75 |
969,75 |
727,31 |
484,88 |
B |
|
|
| Latanoprostum |
S01EE01 |
09-0121-01 |
Latanoprost-ratiopharm 50mcg/ml | Ratiopharm GmbH | acu pilieni, šķīdums |
0.05mg/ ml-2.5ml |
1 gab. |
4,92 |
6,79 |
6,79 |
5,09 |
3,40 |
A |
R |
|
S01EE01 |
09-0393-01 |
UNILAT 50mcg/ml | Unimed Pharma Ltd. | acu pilieni, šķīdums |
0.05mg/ ml-2.5ml |
1 gab. |
5,97 |
8,14 |
6,79 |
5,09 |
3,40 |
A |
|
|
|
S01EE01 |
00-0502-01 |
Xalatan 50mcg/ml | Pfizer Europe MA EEIG | acu pilieni, šķīdums |
0.05mg/ ml-2.5ml |
1 gab. |
6,83 |
9,24 |
6,79 |
5,09 |
3,40 |
A |
|
|
|
S01EE01 |
09-0246-01 |
Xaloptic 0,005% | Pharmaceutical Works "Polpharma" S.A. | acu pilieni, šķīdums |
0.05mg/ ml-2.5ml |
1 gab. |
7,57 |
10,20 |
6,79 |
5,09 |
3,40 |
A |
|
|
|
S01EE01 |
09-0393-02 |
UNILAT 50mcg/ml | Unimed Pharma Ltd. | acu pilieni, šķīdums |
0.05mg/ ml-2.5ml |
3 gab. |
19,17 |
24,48 |
20,33 |
15,25 |
10,17 |
A |
|
|
|
S01EE01 |
00-0502-02 |
Xalatan 50mcg/ml | Pfizer Europe MA EEIG | acu pilieni, šķīdums |
0.05mg/ ml-2.5ml |
3 gab. |
20,10 |
25,60 |
20,33 |
15,25 |
10,17 |
A |
|
|
| Latanoprostum/ Timololum |
S01ED51 |
03-0418-01 |
Xalacom | Pfizer Europe MA EEIG | acu pilieni, šķīdums |
0.05/5mg/ ml-2.5ml |
1 gab. |
8,53 |
11,44 |
7,90 |
5,93 |
3,95 |
A |
|
|
S01ED51 |
03-0418-02 |
Xalacom | Pfizer Europe MA EEIG | acu pilieni, šķīdums |
0.05/5mg/ml-2.5ml |
3 gab. |
27,48 |
34,27 |
23,60 |
17,70 |
11,80 |
A |
|
|
| Lercanidipinum |
C08CA13 |
10-0158-02 |
Ledipin 10mg | Teva Pharma B.V. | apvalkotas tabletes |
10 |
28 |
4,29 |
5,96 |
5,96 |
4,47 |
2,98 |
A |
R |
|
C08CA13 |
10-0066-05 |
Lercanidipine-ratiopharm 10mg | Ratiopharm GmbH | apvalkotas tabletes |
10 |
28 |
4,29 |
5,96 |
5,96 |
4,47 |
2,98 |
A |
R |
|
|
C08CA13 |
09-0290-03 |
Lercanidipine Actavis 10mg | Actavis Group PCT ehf | apvalkotas tabletes |
10 |
28 |
4,29 |
5,96 |
5,96 |
4,47 |
2,98 |
A |
R |
|
|
C08CA13 |
01-0392-03 |
Lercapin 10mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
10 |
28 |
7,90 |
10,63 |
5,96 |
4,47 |
2,98 |
A |
|
|
| Leuprorelinum |
L02AE02 |
05-0198-02 |
Eligard 7,5mg | Astellas Pharma Europe B.V. | pulveris injekcijām ar šķīdinātāju |
7,5 |
1 |
64,15 |
76,61 |
76,61 |
57,46 |
38,31 |
B |
|
|
L02AE02 |
05-0199-02 |
Eligard 22,5mg | Astellas Pharma Europe B.V. | pulveris injekcijām ar šķīdinātāju |
22,5 |
1 |
182,27 |
208,90 |
208,90 |
156,68 |
104,45 |
B |
|
|
| Levonorgestrelum |
G03AC03 |
99-0502-01 |
Mirena 20mcg/24h | Bayer Schering Pharma Oy | intrauterīna sistēma |
52 |
1 |
69,51 |
82,61 |
82,61 |
61,96 |
41,31 |
B |
|
| Lisinoprilum |
C09AA03 |
98-0833-01 |
Diroton 5mg | Gedeon Richter Plc. | tabletes |
5 |
28 |
1,94 |
2,78 |
2,78 |
2,09 |
1,39 |
A |
R |
|
C09AA03 |
98-0831-01 |
Diroton 20mg | Gedeon Richter Plc. | tabletes |
20 |
28 |
4,27 |
5,94 |
4,55 |
3,41 |
2,28 |
A |
|
|
|
C09AA03 |
01-0223-01 |
Lisinopril-Grindeks 20mg | Grindeks AS | tabletes |
20 |
28 |
4,74 |
6,55 |
4,55 |
3,41 |
2,28 |
A |
|
|
|
C09AA03 |
04-0019-04 |
Lisigamma 20mg | Worwag Pharma GmbH & Co.KG | tabletes |
20 |
30 |
3,46 |
4,87 |
4,87 |
3,65 |
2,44 |
A |
R |
|
| Lisinoprilum/ Amlodipinum |
C09BB03 |
09-0036-01 |
Dironorm 10mg/5mg | Gedeon Richter Plc. | tabletes |
10/5 |
30 |
4,89 |
6,74 |
4,89 |
3,67 |
2,45 |
A |
|
|
C09BB03 |
09-0465-01 |
Dironorm 20mg/10mg | Gedeon Richter Plc. | tabletes |
20/10 |
30 |
7,14 |
9,64 |
8,13 |
6,10 |
4,07 |
A |
|
|
| Losartanum |
C09CA01 |
09-0438-03 |
Lorista 50mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
50 |
28 |
3,37 |
4,75 |
3,02 |
2,27 |
1,51 |
A |
|
|
C09CA01 |
96-0155-01 |
Cozaar 50mg | SIA "Merck Sharp & Dohme Latvija" | apvalkotas tabletes |
50 |
28 |
8,21 |
11,02 |
3,02 |
2,27 |
1,51 |
A |
|
|
|
C09CA01 |
06-0092-04 |
Lozap 50mg | Zentiva a.s. | apvalkotas tabletes |
50 |
30 |
2,28 |
3,24 |
3,24 |
2,43 |
1,62 |
A |
R |
|
|
C09CA01 |
07-0142-14 |
Losartan Actavis 50mg | Actavis Group hf | apvalkotas tabletes |
50 |
30 |
2,91 |
4,08 |
3,24 |
2,43 |
1,62 |
A |
|
|
|
C09CA01 |
09-0439-05 |
Lorista 100mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
100 |
28 |
6,31 |
8,58 |
6,02 |
4,52 |
3,01 |
A |
|
|
|
C09CA01 |
04-0343-01 |
Cozaar 100mg | SIA "Merck Sharp & Dohme Latvija" | apvalkotas tabletes |
100 |
28 |
10,43 |
13,85 |
6,02 |
4,52 |
3,01 |
A |
|
|
|
C09CA01 |
06-0093-04 |
Lozap 100mg | Zentiva a.s. | apvalkotas tabletes |
100 |
30 |
4,67 |
6,45 |
6,45 |
4,84 |
3,23 |
A |
R |
|
|
C09CA01 |
07-0143-14 |
Losartan Actavis 100mg | Actavis Group hf | apvalkotas tabletes |
100 |
30 |
6,77 |
9,17 |
6,45 |
4,84 |
3,23 |
A |
|
|
| Losartanum/ Hydrochloro-thiazidum |
C09DA01 |
10-0095-02 |
Lorista H 50mg/12,5mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
50/12.5 |
28 |
2,45 |
3,46 |
3,29 |
2,47 |
1,65 |
A |
|
|
C09DA01 |
01-0029-01 |
Hyzaar 50mg/12,5mg | SIA "Merck Sharp & Dohme Latvija" | apvalkotas tabletes |
50/12.5 |
28 |
11,06 |
14,64 |
3,29 |
2,47 |
1,65 |
A |
|
|
|
C09DA01 |
09-0089-02 |
Lozap H 50/12,5mg | Zentiva k.s. | apvalkotas tabletes |
50/12.5 |
30 |
2,49 |
3,52 |
3,52 |
2,64 |
1,76 |
A |
R |
|
|
C09DA01 |
10-0373-05 |
Lorista H 100mg/12,5mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
100/12.5 |
28 |
5,54 |
7,58 |
7,41 |
5,56 |
3,71 |
A |
|
|
|
C09DA01 |
09-0241-04 |
Fortzaar 100mg/12,5mg | SIA "Merck Sharp & Dohme Latvija" | apvalkotas tabletes |
100/12.5 |
28 |
12,10 |
15,92 |
7,41 |
5,56 |
3,71 |
A |
|
|
|
C09DA01 |
09-0241-07 |
Fortzaar 100mg/12,5mg | SIA "Merck Sharp & Dohme Latvija" | apvalkotas tabletes |
100/12.5 |
56 |
23,74 |
29,88 |
14,83 |
11,12 |
7,42 |
A |
|
|
|
C09DA01 |
10-0096-04 |
Lorista H 100mg/25mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
100/25 |
28 |
5,63 |
7,69 |
7,69 |
5,77 |
3,85 |
A |
R |
|
|
C09DA01 |
09-0242-03 |
Fortzaar 100mg/25mg | SIA "Merck Sharp & Dohme Latvija" | apvalkotas tabletes |
100/25 |
28 |
10,84 |
14,36 |
7,69 |
5,77 |
3,85 |
A |
|
|
| Metforminum |
A10BA02 |
00-0570-02 |
Metformin-ratiopharm 500mg | Ratiopharm GmbH | apvalkotas tabletes |
500 |
120 |
2,73 |
3,84 |
3,84 |
2,88 |
1,92 |
A |
R |
|
A10BA02 |
02-0345-02 |
Metfogamma 500mg | Worwag Pharma GmbH & Co.KG | apvalkotas tabletes |
500 |
120 |
3,32 |
4,68 |
3,84 |
2,88 |
1,92 |
A |
|
|
|
A10BA02 |
00-1080-03 |
Metforal 500mg | Berlin-Chemie AG (Menarini Group) | apvalkotas tabletes |
500 |
120 |
3,72 |
5,21 |
3,84 |
2,88 |
1,92 |
A |
|
|
|
A10BA02 |
00-0571-02 |
Metformin-ratiopharm 850mg | Ratiopharm GmbH | apvalkotas tabletes |
850 |
120 |
5,08 |
6,99 |
6,48 |
4,86 |
3,24 |
A |
|
|
|
A10BA02 |
00-0993-02 |
Metfogamma 850mg | Worwag Pharma GmbH & Co.KG | apvalkotas tabletes |
850 |
120 |
5,29 |
7,26 |
6,48 |
4,86 |
3,24 |
A |
|
|
|
A10BA02 |
00-1081-03 |
Metforal 850mg | Berlin-Chemie AG (Menarini Group) | apvalkotas tabletes |
850 |
120 |
5,60 |
7,66 |
6,48 |
4,86 |
3,24 |
A |
|
|
|
A10BA02 |
05-0257-04 |
Stadamet 1000mg | Stada Arzneimittel AG | apvalkotas tabletes |
1000 |
120 |
6,09 |
8,29 |
7,56 |
5,67 |
3,78 |
A |
|
|
|
A10BA02 |
05-0096-05 |
Metforal 1000mg | Berlin-Chemie AG | apvalkotas tabletes |
1000 |
120 |
6,52 |
8,85 |
7,56 |
5,67 |
3,78 |
A |
|
|
|
A10BA02 |
07-0390-02 |
Metfogamma 1000mg | Worwag Pharma GmbH & Co.KG | apvalkotas tabletes |
1000 |
120 |
6,52 |
8,85 |
7,56 |
5,67 |
3,78 |
A |
|
|
| Methoxy polyethylene glycol-epoetinum beta |
B03XA03 |
EU/1/07/400/017 |
Mircera | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.03mg/ 0.3ml |
1 |
43,30 |
52,89 |
47,79 |
35,84 |
23,90 |
A |
|
|
B03XA03 |
EU/1/07/400/008 |
Mircera | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.05mg/ 0.3ml |
1 |
72,42 |
85,87 |
77,76 |
58,32 |
38,88 |
A |
|
|
|
B03XA03 |
EU/1/07/400/009 |
Mircera | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.075mg/ 0.3ml |
1 |
105,87 |
123,33 |
111,47 |
83,60 |
55,74 |
A |
|
|
|
B03XA03 |
EU/1/07/400/010 |
Mircera | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.1mg/ 0.3ml |
1 |
142,55 |
164,42 |
148,46 |
111,35 |
74,23 |
A |
|
|
|
B03XA03 |
EU/1/07/400/020 |
Mircera | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.12mg/ 0.3ml |
1 |
167,81 |
192,71 |
173,91 |
130,43 |
86,96 |
A |
|
|
|
B03XA03 |
EU/1/07/400/012 |
Mircera | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.2mg/ 0.3ml |
1 |
280,02 |
318,38 |
287,02 |
215,27 |
143,51 |
A |
|
|
|
B03XA03 |
EU/1/07/400/021 |
Mircera | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.36mg/ 0.6ml |
1 |
491,50 |
555,24 |
500,19 |
375,14 |
250,10 |
A |
|
|
| Methyl-prednisolonum |
H02AB04 |
99-1042-01 |
Medrol 4mg | Pfizer Europe MA EEIG | tabletes |
4 |
30 |
1,89 |
2,70 |
2,70 |
2,03 |
1,35 |
B |
|
|
H02AB04 |
99-1042-02 |
Medrol 4mg | Pfizer Europe MA EEIG | tabletes |
4 |
100 |
4,76 |
6,57 |
6,57 |
4,93 |
3,29 |
B |
|
|
|
H02AB04 |
99-1043-01 |
Medrol 16mg | Pfizer Europe MA EEIG | tabletes |
16 |
50 |
8,32 |
11,17 |
11,17 |
8,38 |
5,59 |
B |
|
|
| Montelukastum |
R03DC03 |
01-0294-03 |
Singulair 4mg | SIA "Merck Sharp & Dohme Latvija" | košļājamas tabletes |
4 |
28 |
19,46 |
24,83 |
24,83 |
18,62 |
12,42 |
B |
|
|
R03DC03 |
02-0351-01 |
Singulair mini 4mg | SIA "Merck Sharp & Dohme Latvija" | granulas iekšķīgai lietošanai |
4 |
28 |
20,66 |
26,25 |
26,25 |
19,69 |
13,13 |
B |
|
|
|
R03DC03 |
98-0355-01 |
Singulair 5mg | SIA "Merck Sharp & Dohme Latvija" | košļājamas tabletes |
5 |
28 |
19,46 |
24,83 |
24,83 |
18,62 |
12,42 |
B |
|
|
|
R03DC03 |
98-0354-01 |
Singulair 10mg | SIA "Merck Sharp & Dohme Latvija" | apvalkotas tabletes |
10 |
28 |
19,46 |
24,83 |
24,83 |
18,62 |
12,42 |
B |
|
|
| Natrii alendronatum/ Cholecalciferolum |
M05BB03 |
EU/1/05/310/002 |
Fosavance | Merck Sharp & Dohme Ltd. | tabletes |
70/0.07 |
4 |
13,61 |
17,77 |
9,42 |
7,07 |
4,71 |
A |
|
|
M05BB03 |
EU/1/05/310/007 |
Fosavance | Merck Sharp & Dohme Ltd. | tabletes |
70/0.14 |
4 |
12,20 |
16,04 |
9,58 |
7,19 |
4,79 |
A |
|
|
|
M05BB03 |
EU/1/05/310/008 |
Fosavance | Merck Sharp & Dohme Ltd. | tabletes |
70/0.14 |
12 |
35,92 |
44,21 |
28,74 |
21,56 |
14,37 |
A |
|
|
| Natrii risedronatum |
M05BA07 |
08-0308-03 |
Norifaz 35mg | Zaklad Farmaceutyczny Adamed Pharma S.A. | apvalkotas tabletes |
35 |
4 |
6,84 |
9,26 |
9,26 |
6,95 |
4,63 |
A |
R |
|
M05BA07 |
09-0049-01 |
Ribidron 35mg | Ratiopharm GmbH | apvalkotas tabletes |
35 |
4 |
6,84 |
9,26 |
9,26 |
6,95 |
4,63 |
A |
R |
|
|
M05BA07 |
08-0339-03 |
Risonate 35mg | Teva Pharma B.V. | apvalkotas tabletes |
35 |
4 |
6,84 |
9,26 |
9,26 |
6,95 |
4,63 |
A |
R |
|
|
M05BA07 |
08-0309-03 |
Risedronate Sodium Actavis 35mg | Actavis Group PCT ehf | apvalkotas tabletes |
35 |
4 |
7,71 |
10,38 |
9,26 |
6,95 |
4,63 |
A |
|
|
|
M05BA07 |
07-0271-02 |
Risendros 35mg | Zentiva k.s. | apvalkotas tabletes |
35 |
4 |
7,76 |
10,44 |
9,26 |
6,95 |
4,63 |
A |
|
|
|
M05BA07 |
05-0570-01 |
Actonel 35mg OAW | Sanofi-aventis Latvia SIA | apvalkotas tabletes |
35 |
4 |
14,18 |
18,48 |
9,26 |
6,95 |
4,63 |
A |
|
|
|
M05BA07 |
07-0271-04 |
Risendros 35mg | Zentiva k.s. | apvalkotas tabletes |
35 |
12 |
21,95 |
27,78 |
27,78 |
20,84 |
13,89 |
A |
R |
|
| Nebivololum |
C07AB12 |
07-0383-01 |
Nebivolol Orion 5mg | Orion Corporation | tabletes |
5 |
30 |
2,70 |
3,80 |
3,48 |
2,61 |
1,74 |
A |
|
|
C07AB12 |
98-0344-08 |
Nebilet 5mg | Menarini International Operations Luxembourg S.A. | tabletes |
5 |
90 |
12,42 |
16,31 |
9,86 |
7,40 |
4,93 |
A |
|
|
| Nevirapinum |
J05AG01 |
EU/1/97/055/001 |
Viramune | Boehringer Ingelheim International GmbH | tabletes |
200 |
60 |
122,62 |
142,09 |
142,09 |
106,57 |
71,05 |
B |
|
| Octreotidum |
H01CB02 |
98-0429-01 |
Sandostatin LAR 20mg | Novartis Finland Oy | pulveris un šķīdinātājs injekciju suspensijas pagatavo-šanai |
20 |
1 |
597,30 |
673,74 |
673,74 |
505,31 |
336,87 |
B |
|
| Olanzapinum |
N05AH03 |
EU/1/07/427/023 |
Olanzapine Teva | Teva Pharma B.V. | mutē disperģēja-mas tabletes |
5 |
28 |
11,02 |
14,58 |
14,58 |
10,94 |
7,29 |
A |
R |
|
N05AH03 |
EU/1/07/415/033 |
Zalasta | KRKA d.d., Novo Mesto | mutē disperģēja-mas tabletes |
5 |
28 |
11,02 |
14,58 |
14,58 |
10,94 |
7,29 |
A |
R |
|
|
N05AH03 |
EU/1/99/125/001 |
Zyprexa Velotab | Eli Lilly Nederland BV | mutē disperģēja-mas tabletes |
5 |
28 |
35,16 |
43,31 |
14,58 |
10,94 |
7,29 |
A |
|
|
|
N05AH03 |
09-0390-02 |
Lapozan 5mg | Medochemie Ltd. | mutē disperģēja-mas tabletes |
5 |
30 |
11,86 |
15,62 |
15,62 |
11,72 |
7,81 |
A |
R |
|
|
N05AH03 |
07-0281-04 |
Olanzapin-ratiopharm 10mg | Ratiopharm GmbH | tabletes |
10 |
28 |
22,03 |
27,87 |
27,87 |
20,90 |
13,94 |
A |
R |
|
|
N05AH03 |
EU/1/07/427/027 |
Olanzapine Teva | Teva Pharma B.V. | mutē disperģēja-mas tabletes |
10 |
28 |
22,03 |
27,87 |
27,87 |
20,90 |
13,94 |
A |
R |
|
|
N05AH03 |
EU/1/07/415/043 |
Zalasta | KRKA d.d., Novo Mesto | mutē disperģēja-mas tabletes |
10 |
28 |
22,03 |
27,87 |
27,87 |
20,90 |
13,94 |
A |
R |
|
|
N05AH03 |
EU/1/99/125/002 |
Zyprexa Velotab | Eli Lilly Nederland BV | mutē disperģēja-mas tabletes |
10 |
28 |
69,76 |
82,89 |
27,87 |
20,90 |
13,94 |
A |
|
|
|
N05AH03 |
09-0391-02 |
Lapozan 10mg | Medochemie Ltd. | mutē disperģēja-mas tabletes |
10 |
30 |
23,72 |
29,86 |
29,86 |
22,40 |
14,93 |
A |
R |
|
| Olmesartanum |
C09CA08 |
09-0440-02 |
Olimestra 10mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
10 |
28 |
2,80 |
3,93 |
1,51 |
1,13 |
0,76 |
A |
|
|
C09CA08 |
04-0062-01 |
Mesar 10mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
10 |
28 |
11,12 |
14,71 |
1,51 |
1,13 |
0,76 |
A |
|
|
|
C09CA08 |
09-0441-02 |
Olimestra 20mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
20 |
28 |
5,74 |
7,84 |
3,02 |
2,27 |
1,51 |
A |
|
|
|
C09CA08 |
04-0063-01 |
Mesar 20mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
20 |
28 |
13,28 |
17,37 |
3,02 |
2,27 |
1,51 |
A |
|
|
|
C09CA08 |
09-0442-02 |
Olimestra 40mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
40 |
28 |
7,22 |
9,74 |
6,02 |
4,52 |
3,01 |
A |
|
|
|
C09CA08 |
04-0064-01 |
Mesar 40mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
40 |
28 |
16,23 |
20,97 |
6,02 |
4,52 |
3,01 |
A |
|
|
| Olmesartanum/ Amlodipinum |
C09DB02 |
08-0270-02 |
Sanoral 20mg/5mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
20/5 |
28 |
13,32 |
17,42 |
4,95 |
3,71 |
2,48 |
A |
|
|
C09DB02 |
08-0271-02 |
Sanoral 40mg/5mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
40/5 |
28 |
13,85 |
18,08 |
7,94 |
5,96 |
3,97 |
A |
|
|
|
C09DB02 |
08-0272-02 |
Sanoral 40mg/10mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
40/10 |
28 |
13,85 |
18,08 |
9,06 |
6,80 |
4,53 |
A |
|
|
| Olmesartanum/ Hydrochloro-thiazidum |
C09DA08 |
05-0631-02 |
Mesar Plus 20/12,5mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
20/12.5 |
28 |
13,28 |
17,37 |
3,29 |
2,47 |
1,65 |
A |
|
|
C09DA08 |
05-0632-02 |
Mesar Plus 20/25mg | Menarini International Operations Luxembourg S.A. | apvalkotas tabletes |
20/25 |
28 |
13,28 |
17,37 |
5,81 |
4,36 |
2,91 |
A |
|
|
| Ondansetronum |
A04AA01 |
00-0335-01 |
Emetron 8mg | Gedeon Richter Plc. | apvalkotas tabletes |
8 |
10 |
11,26 |
14,88 |
14,88 |
11,16 |
7,44 |
A |
R |
|
A04AA01 |
98-0617-01 |
Zofran 8mg/4ml | GlaxoSmithKline Latvia SIA | šķīdums injekcijām |
8mg/4ml |
5 |
11,26 |
14,88 |
14,88 |
11,16 |
7,44 |
A |
R |
|
|
A04AA01 |
00-0333-01 |
Emetron 2mg/ml | Gedeon Richter Plc. | šķīdums injekcijām |
8mg/4ml |
5 |
22,69 |
28,64 |
14,88 |
11,16 |
7,44 |
A |
|
|
| Pegfilgrastimum |
L03AA13 |
EU/1/02/227/002 |
Neulasta | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
6mg/ 0.6ml |
1 |
637,98 |
719,30 |
719,30 |
539,48 |
359,65 |
B |
|
| Peginterferonum alfa-2a |
L03AB11 |
EU/1/02/221/005 |
Pegasys | Roche Registration Limited | šķīdums injekcijām pilnšļircē |
0.135mg/ 0.5ml |
1 |
109,79 |
127,72 |
127,72 |
95,79 |
63,86 |
B |
|
| Peginterferonum alfa-2a + Ribavirinum |
L03AB11 + J05AB04 |
EU/1/02/221/007 |
Pegasys 180mcg/0,5ml Nr.1 (4 oriģ.)+ Copegus 200mg Nr.168 (1 oriģ.) | Roche Registration Limited | šķīdums injekcijām pilnšļircē + apvalkotas tabletes |
0.18mg/ 0.5ml + 200mg |
1 kompl. |
521,66 |
589,02 |
589,02 |
441,77 |
294,51 |
B |
|
| Peginterferonum alfa-2b + Ribavirinum |
L03AB10 + J05AB04 |
EU/1/00/131/031 + |
PegIntron 0,05mg Nr.1 (4 oriģ.) + Rebetol 200mg Nr.140 (1 oriģ.) | Schering-Plough Europe | pulveris injekcijām ar šķīdinātāju pilnšļircē + cietas kapsulas |
0.05 + 200 |
1 kompl. |
244,39 |
278,48 |
278,48 |
208,86 |
139,24 |
B |
|
|
L03AB10 + J05AB04 |
EU/1/00/131/035 |
PegIntron 0,08mg Nr.1 (4 oriģ.) + Rebetol 200mg Nr.140 (1 oriģ.) | Schering-Plough Europe | pulveris injekcijām ar šķīdinātāju pilnšļircē + cietas kapsulas |
0.08 + 200 |
1 kompl. |
393,56 |
445,55 |
445,55 |
334,16 |
222,78 |
B |
|
|
|
L03AB10 + J05AB04 |
EU/1/00/131/039 + EU/1/99/107/002 |
PegIntron 0,1mg Nr.1 (4 oriģ.) + Rebetol 200mg Nr.140 (1 oriģ.) | Schering-Plough Europe | pulveris injekcijām ar šķīdinātāju pilnšļircē + cietas kapsulas |
0.1 + 200 |
1 kompl. |
493,00 |
556,92 |
556,92 |
417,69 |
278,46 |
B |
|
|
|
L03AB10 + J05AB04 |
EU/1/00/131/043 + EU/1/99/107/002 |
PegIntron 0,12mg Nr.1 (4 oriģ.) + Rebetol 200mg Nr.140 (1 oriģ.) | Schering-Plough Europe | pulveris injekcijām ar šķīdinātāju pilnšļircē + cietas kapsulas |
0.12 + 200 |
1 kompl. |
592,44 |
668,29 |
668,29 |
501,22 |
334,15 |
B |
|
|
|
L03AB10 + J05AB04 |
EU/1/00/131/047 + EU/1/99/107/002 |
PegIntron 0,15mg Nr.1 (4 oriģ.) + Rebetol 200mg Nr.140 (1 oriģ.) | Schering-Plough Europe | pulveris injekcijām ar šķīdinātāju pilnšļircē + cietas kapsulas |
0.15 + 200 |
1 kompl. |
741,60 |
835,35 |
835,35 |
626,51 |
417,68 |
B |
|
|
| Pramipexolum |
N04BC05 |
09-0160-01 |
Ezaprev 0,18mg | Norameda UAB | tabletes |
0,18 |
30 |
3,00 |
4,27 |
4,27 |
3,20 |
2,14 |
A |
R |
|
N04BC05 |
09-0269-01 |
Medopexol 0,18mg | Medochemie Ltd. | tabletes |
0,18 |
30 |
3,00 |
4,27 |
4,27 |
3,20 |
2,14 |
A |
R |
|
|
N04BC05 |
09-0270-01 |
Medopexol 0,7mg | Medochemie Ltd. | tabletes |
0,7 |
30 |
13,03 |
17,06 |
17,06 |
12,80 |
8,53 |
A |
R |
|
| Quetiapinum |
N05AH04 |
07-0334-04 |
Ketilept 200mg | Egis Pharmaceuticals PLC | apvalkotas tabletes |
200 |
60 |
28,06 |
34,96 |
34,96 |
26,22 |
17,48 |
A |
R |
|
N05AH04 |
07-0232-05 |
Kventiax 200mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
200 |
60 |
28,06 |
34,96 |
34,96 |
26,22 |
17,48 |
A |
R |
|
|
N05AH04 |
07-0375-02 |
Nantarid 200mg | Gedeon Richter Plc. | apvalkotas tabletes |
200 |
60 |
28,06 |
34,96 |
34,96 |
26,22 |
17,48 |
A |
R |
|
|
N05AH04 |
08-0340-06 |
Quetiapine Teva 200mg | Teva Pharma B.V. | apvalkotas tabletes |
200 |
60 |
28,06 |
34,96 |
34,96 |
26,22 |
17,48 |
A |
R |
|
|
N05AH04 |
10-0131-01 |
Quetiapine Polpharma 200mg | Pharmaceutical Works "Polpharma" S.A. | apvalkotas tabletes |
200 |
60 |
29,54 |
36,70 |
34,96 |
26,22 |
17,48 |
A |
|
|
|
N05AH04 |
07-0269-09 |
Hedonin 200mg | Lannacher Heilmittel GmbH | apvalkotas tabletes |
200 |
60 |
31,20 |
38,65 |
34,96 |
26,22 |
17,48 |
A |
|
|
|
N05AH04 |
09-0111-14 |
Quetiapine Actavis 200mg | Actavis Group PCT ehf | apvalkotas tabletes |
200 |
60 |
31,20 |
38,65 |
34,96 |
26,22 |
17,48 |
A |
|
|
|
N05AH04 |
01-0121-02 |
Seroquel 200mg | AstraZeneca UK Limited | apvalkotas tabletes |
200 |
60 |
31,20 |
38,65 |
34,96 |
26,22 |
17,48 |
A |
|
|
|
N05AH04 |
07-0097-01 |
Ketipinor 200mg | Orion Corporation | apvalkotas tabletes |
200 |
100 |
47,82 |
58,20 |
58,20 |
43,65 |
29,10 |
A |
R |
|
|
N05AH04 |
07-0233-05 |
Kventiax 300mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
300 |
60 |
42,88 |
52,38 |
52,38 |
39,29 |
26,19 |
A |
R |
|
|
N05AH04 |
07-0376-02 |
Nantarid 300mg | Gedeon Richter Plc. | apvalkotas tabletes |
300 |
60 |
45,13 |
55,04 |
52,38 |
39,29 |
26,19 |
A |
|
|
|
N05AH04 |
10-0132-01 |
Quetiapine Polpharma 300mg | Pharmaceutical Works "Polpharma" S.A. | apvalkotas tabletes |
300 |
60 |
47,58 |
57,92 |
52,38 |
39,29 |
26,19 |
A |
|
|
|
N05AH04 |
08-0014-01 |
Seroquel XR 300mg | AstraZeneca UK Limited | ilgstošas darbības apvalkotas tabletes |
300 |
60 |
57,80 |
69,50 |
62,87 |
47,15 |
31,44 |
A |
|
|
|
N05AH04 |
08-0015-01 |
Seroquel XR 400mg | AstraZeneca UK Limited | ilgstošas darbības apvalkotas tabletes |
400 |
60 |
78,44 |
92,61 |
83,76 |
62,82 |
41,88 |
A |
|
|
| Quinaprilum/ Hydrochloro-thiazidum |
C09BA06 |
09-0531-03 |
Quinapril/HCT Teva 10mg/12,5mg | Teva Pharma B.V. | apvalkotas tabletes |
10/12.5 |
30 |
2,66 |
3,74 |
3,74 |
2,81 |
1,87 |
A |
R |
|
C09BA06 |
01-0279-01 |
Accuzide 10mg/12,5mg | Pfizer Limited | apvalkotas tabletes |
10/12.5 |
30 |
2,80 |
3,93 |
3,74 |
2,81 |
1,87 |
A |
|
|
| Ramiprilum |
C09AA05 |
04-0388-04 |
Ramicor 5mg | Hexal AG | tabletes |
5 |
30 |
2,83 |
3,98 |
3,26 |
2,45 |
1,63 |
A |
|
|
C09AA05 |
04-0389-08 |
Ramicor 10mg | Hexal AG | tabletes |
10 |
60 |
9,01 |
12,05 |
11,28 |
8,46 |
5,64 |
A |
|
|
| Ramiprilum/ Hydrochloro-thiazidum |
C09BA05 |
04-0184-01 |
Co-Ramicor 5mg/25mg | Hexal AG | tabletes |
5/25 |
30 |
5,64 |
7,72 |
6,01 |
4,51 |
3,01 |
A |
|
| Ribavirinum |
J05AB04 |
03-0114-02 |
Ribavirin 200mg | Olainfarm A/S | kapsulas |
200 |
20 |
10,00 |
13,33 |
13,33 |
10,00 |
6,67 |
A |
R |
| Ropinirolum |
N04BC04 |
08-0263-02 |
Ropinirol Orion 0,25mg | Orion Corporation | apvalkotas tabletes |
0,25 |
84 |
2,64 |
3,72 |
3,72 |
2,79 |
1,86 |
A |
R |
|
N04BC04 |
08-0265-02 |
Ropinirol Orion 1mg | Orion Corporation | apvalkotas tabletes |
1 |
84 |
11,25 |
14,87 |
14,87 |
11,15 |
7,44 |
A |
R |
|
|
N04BC04 |
06-0261-02 |
Requip-Modutab 2mg | GlaxoSmithKline Latvia SIA | ilgstošas darbības tabletes |
2 |
28 |
7,88 |
10,60 |
9,92 |
7,44 |
4,96 |
A |
|
|
|
N04BC04 |
06-0261-03 |
Requip-Modutab 2mg | GlaxoSmithKline Latvia SIA | ilgstošas darbības tabletes |
2 |
84 |
24,48 |
30,74 |
29,03 |
21,77 |
14,52 |
A |
|
|
|
N04BC04 |
06-0263-02 |
Requip-Modutab 4mg | GlaxoSmithKline Latvia SIA | ilgstošas darbības tabletes |
4 |
84 |
49,32 |
59,96 |
57,76 |
43,32 |
28,88 |
A |
|
|
|
N04BC04 |
06-0264-02 |
Requip-Modutab 8mg | GlaxoSmithKline Latvia SIA | ilgstošas darbības tabletes |
8 |
84 |
96,56 |
112,91 |
109,20 |
81,90 |
54,60 |
A |
|
|
| Rosuvastatinum |
C10AA07 |
03-0167-02 |
Crestor 10mg | AstraZeneca UK Limited | apvalkotas tabletes |
10 |
28 |
10,61 |
14,08 |
4,73 |
3,55 |
2,37 |
A |
|
|
C10AA07 |
10-0007-02 |
Rosuvacard 10mg | Zentiva k.s. | apvalkotas tabletes |
10 |
30 |
4,90 |
6,75 |
5,07 |
3,80 |
2,54 |
A |
|
|
|
C10AA07 |
10-0178-01 |
Zaranta 10mg | Gedeon Richter Plc. | apvalkotas tabletes |
10 |
30 |
5,60 |
7,66 |
5,07 |
3,80 |
2,54 |
A |
|
|
|
C10AA07 |
03-0168-02 |
Crestor 20mg | AstraZeneca UK Limited | apvalkotas tabletes |
20 |
28 |
16,57 |
21,37 |
9,41 |
7,06 |
4,71 |
A |
|
|
|
C10AA07 |
10-0008-02 |
Rosuvacard 20mg | Zentiva k.s. | apvalkotas tabletes |
20 |
30 |
9,18 |
12,28 |
10,08 |
7,56 |
5,04 |
A |
|
|
|
C10AA07 |
10-0179-01 |
Zaranta 20mg | Gedeon Richter Plc. | apvalkotas tabletes |
20 |
30 |
10,51 |
13,96 |
10,08 |
7,56 |
5,04 |
A |
|
|
|
C10AA07 |
03-0169-02 |
Crestor 40 mg | AstraZeneca UK Limited | apvalkotas tabletes |
40 |
28 |
28,17 |
35,09 |
16,50 |
12,38 |
8,25 |
A |
|
|
|
C10AA07 |
10-0180-01 |
Zaranta 40mg | Gedeon Richter Plc. | apvalkotas tabletes |
40 |
30 |
14,90 |
19,36 |
17,68 |
13,26 |
8,84 |
A |
|
|
| Salmeterolum/ Fluticasonum |
R03AK06 |
01-0451-01 |
Seretide 25/50mcg/dose | GlaxoSmithKline Latvia SIA | aerosols inhalācijām |
0.025/ 0.05mg devā |
120 devas |
15,84 |
20,50 |
20,50 |
15,38 |
10,25 |
A |
R |
|
R03AK06 |
01-0452-01 |
Seretide 25/125mcg/dose | GlaxoSmithKline Latvia SIA | aerosols inhalācijām |
0.025/ 0.125mg devā |
120 devas |
22,64 |
28,58 |
28,58 |
21,44 |
14,29 |
A |
R |
|
|
R03AK06 |
01-0453-01 |
Seretide 25/250mcg/dose | GlaxoSmithKline Latvia SIA | aerosols inhalācijām |
0.025/ 0.25mg devā |
120 devas |
30,97 |
38,38 |
38,38 |
28,79 |
19,19 |
A |
R |
|
|
R03AK06 |
00-0933-01 |
Seretide Diskus 50/100mcg/dose | GlaxoSmithKline Latvia SIA | pulveris inhalācijām |
0.05/ 0.1mg devā |
60 devas |
16,13 |
20,84 |
20,84 |
15,63 |
10,42 |
A |
R |
|
|
R03AK06 |
00-0933-02 |
Seretide Diskus 50/100mcg/dose | GlaxoSmithKline Latvia SIA | pulveris inhalācijām |
0.05/ 0.1mg devā |
180 devas |
51,36 |
62,28 |
62,28 |
46,71 |
31,14 |
A |
R |
|
|
R03AK06 |
00-0934-01 |
Seretide Diskus 50/250mcg/dose | GlaxoSmithKline Latvia SIA | pulveris inhalācijām |
0.05/ 0.25mg devā |
60 devas |
21,62 |
27,38 |
27,38 |
20,54 |
13,69 |
A |
R |
|
|
R03AK06 |
00-0934-02 |
Seretide Diskus 50/250mcg/dose | GlaxoSmithKline Latvia SIA | pulveris inhalācijām |
0.05/ 0.25mg devā |
180 devas |
68,88 |
81,91 |
81,91 |
61,43 |
40,96 |
A |
R |
|
|
R03AK06 |
00-0935-01 |
Seretide Diskus 50/500mcg/dose | GlaxoSmithKline Latvia SIA | pulveris inhalācijām |
0.05/ 0.5mg devā |
60 devas |
29,85 |
37,06 |
37,06 |
27,80 |
18,53 |
A |
R |
|
|
R03AK06 |
00-0935-02 |
Seretide Diskus 50/500mcg/dose | GlaxoSmithKline Latvia SIA | pulveris inhalācijām |
0.05/ 0.5mg devā |
180 devas |
94,91 |
111,06 |
111,06 |
83,30 |
55,53 |
A |
R |
|
| Saquinavirum |
J05AE01 |
EU/1/96/026/002 |
Invirase | Roche Registration Limited | apvalkotas tabletes |
500 |
120 |
193,69 |
221,69 |
221,69 |
166,27 |
110,85 |
B |
|
| Sirolimum |
L04AA10 |
EU/1/01/171/007 |
Rapamune | Wyeth Europa Ltd | apvalkotas tabletes |
1 |
30 |
81,02 |
95,50 |
95,50 |
71,63 |
47,75 |
B |
|
| Tafluprostum |
S01EE05 |
09-0234-01 |
Taflotan 15mcg/ml | Santen Oy | acu pilieni |
0.015mg/ml-0.3ml |
30 devas |
13,78 |
17,99 |
7,28 |
5,46 |
3,64 |
A |
|
| Tamsulosinum |
G04CA02 |
05-0554-01 |
Tanyz 0,4 mg | KRKA d.d., Novo Mesto | ilgstošas darbības cietas kapsulas |
0.4 |
30 |
3,55 |
4,98 |
4,98 |
3,74 |
2,49 |
A |
R |
|
G04CA02 |
06-0038-01 |
Fokusin 0,4mg | Zentiva k.s. | ilgstošas darbības cietas kapsulas |
0.4 |
30 |
4,46 |
6,18 |
4,98 |
3,74 |
2,49 |
A |
|
|
|
G04CA02 |
06-0089-01 |
Omsal 0,4mg | Gedeon Richter Plc. | ilgstošas darbības kapsulas |
0.4 |
30 |
4,51 |
6,25 |
4,98 |
3,74 |
2,49 |
A |
|
|
|
G04CA02 |
06-0109-01 |
Tamsulosin Lannacher 0,4mg | Lannacher Heilmittel GmbH | ilgstošas darbības cietas kapsulas |
0.4 |
30 |
4,79 |
6,61 |
4,98 |
3,74 |
2,49 |
A |
|
|
|
G04CA02 |
05-0618-01 |
Urostad 0,4mg | Stada Arzneimittel AG | ilgstošas darbības cietas kapsulas |
0.4 |
30 |
7,97 |
10,72 |
4,98 |
3,74 |
2,49 |
A |
|
|
|
G04CA02 |
06-0031-01 |
Flosin 0,4mg | Menarini International Operations Luxembourg S.A. | ilgstošas darbības cietas kapsulas |
0.4 |
30 |
8,27 |
11,10 |
4,98 |
3,74 |
2,49 |
A |
|
|
|
G04CA02 |
05-0100-05 |
Omnic Tocas 0,4mg | Astellas Pharma Europe B.V. | ilgstošas darbības tabletes |
0.4 |
30 |
8,41 |
11,28 |
4,98 |
3,74 |
2,49 |
A |
|
|
|
G04CA02 |
06-0038-02 |
Fokusin 0,4mg | Zentiva k.s. | ilgstošas darbības cietas kapsulas |
0.4 |
90 |
13,29 |
17,38 |
14,94 |
11,21 |
7,47 |
A |
|
|
| Telmisartanum |
C09CA07 |
EU/1/10/632/009 |
Tolura 40mg | KRKA d.d., Novo Mesto | tabletes |
40 |
28 |
5,34 |
7,32 |
3,02 |
2,27 |
1,51 |
A |
|
|
C09CA07 |
EU/1/98/089/002 |
Pritor | Bayer Schering Pharma AG | tabletes |
40 |
28 |
9,79 |
13,06 |
3,02 |
2,27 |
1,51 |
A |
|
|
|
C09CA07 |
EU/1/98/090/002 |
Micardis 40mg | Boehringer Ingelheim International GmbH | tabletes |
40 |
28 |
9,79 |
13,06 |
3,02 |
2,27 |
1,51 |
A |
|
|
|
C09CA07 |
10-0174-01 |
Tezeo 40mg | Zentiva k.s. | tabletes |
40 |
30 |
4,15 |
5,78 |
3,24 |
2,43 |
1,62 |
A |
|
|
|
C09CA07 |
EU/1/10/632/016 |
Tolura 80mg | KRKA d.d., Novo Mesto | tabletes |
80 |
28 |
6,71 |
9,09 |
6,02 |
4,52 |
3,01 |
A |
|
|
|
C09CA07 |
EU/1/98/090/006 |
Micardis 80mg | Boehringer Ingelheim International GmbH | tabletes |
80 |
28 |
12,36 |
16,24 |
6,02 |
4,52 |
3,01 |
A |
|
|
|
C09CA07 |
EU/1/98/089/007 |
Pritor | Bayer Schering Pharma AG | tabletes |
80 |
28 |
12,36 |
16,24 |
6,02 |
4,52 |
3,01 |
A |
|
|
|
C09CA07 |
10-0175-01 |
Tezeo 80mg | Zentiva k.s. | tabletes |
80 |
30 |
6,14 |
8,36 |
6,45 |
4,84 |
3,23 |
A |
|
|
| Telmisartanum/ Hydrochloro-thiazidum |
C09DA07 |
EU/1/02/213/007 |
MicardisPlus | Boehringer Ingelheim International GmbH | tabletes |
80/12.5 |
28 |
12,36 |
16,24 |
7,41 |
5,56 |
3,71 |
A |
|
|
C09DA07 |
EU/1/02/215/007 |
PritorPlus | Bayer Schering Pharma AG | tabletes |
80/12.5 |
28 |
12,36 |
16,24 |
7,41 |
5,56 |
3,71 |
A |
|
|
|
C09DA07 |
EU/1/02/213/018 |
MicardisPlus | Boehringer Ingelheim International GmbH | tabletes |
80/25 |
28 |
12,36 |
16,24 |
7,69 |
5,77 |
3,85 |
A |
|
|
|
C09DA07 |
EU/1/02/215/016 |
PritorPlus | Bayer Schering Pharma AG | tabletes |
80/25 |
28 |
12,36 |
16,24 |
7,69 |
5,77 |
3,85 |
A |
|
|
| Topiramatum |
N03AX11 |
00-0120-02 |
Topamax 25mg | UAB Johnson & Johnson | apvalkotas tabletes |
25 |
60 |
4,40 |
6,10 |
6,10 |
4,58 |
3,05 |
A |
R |
|
N03AX11 |
08-0283-01 |
Topiramat Orion 25mg | Orion Corporation | apvalkotas tabletes |
25 |
60 |
4,40 |
6,10 |
6,10 |
4,58 |
3,05 |
A |
R |
|
|
N03AX11 |
06-0235-08 |
Topiramate Sandoz 50mg | Sandoz d.d. | apvalkotas tabletes |
50 |
60 |
9,12 |
12,20 |
12,20 |
9,15 |
6,10 |
A |
R |
|
|
N03AX11 |
00-0121-02 |
Topamax 50mg | UAB Johnson & Johnson | apvalkotas tabletes |
50 |
60 |
9,12 |
12,20 |
12,20 |
9,15 |
6,10 |
A |
R |
|
|
N03AX11 |
08-0284-01 |
Topiramat Orion 50mg | Orion Corporation | apvalkotas tabletes |
50 |
60 |
9,12 |
12,20 |
12,20 |
9,15 |
6,10 |
A |
R |
|
|
N03AX11 |
06-0236-08 |
Topiramate Sandoz 100mg | Sandoz d.d. | apvalkotas tabletes |
100 |
60 |
17,52 |
22,51 |
22,51 |
16,88 |
11,26 |
A |
R |
|
|
N03AX11 |
00-0122-02 |
Topamax 100mg | UAB Johnson & Johnson | apvalkotas tabletes |
100 |
60 |
17,52 |
22,51 |
22,51 |
16,88 |
11,26 |
A |
R |
|
|
N03AX11 |
08-0285-01 |
Topiramat Orion 100mg | Orion Corporation | apvalkotas tabletes |
100 |
60 |
17,52 |
22,51 |
22,51 |
16,88 |
11,26 |
A |
R |
|
|
N03AX11 |
08-0286-01 |
Topiramat Orion 200mg | Orion Corporation | apvalkotas tabletes |
200 |
60 |
36,52 |
44,91 |
44,91 |
33,68 |
22,46 |
A |
R |
|
| Topotecanum |
L01XX17 |
EU/1/96/027/005 |
Hycamtin | SmithKline Beecham plc | pulveris infūziju šķīduma koncentrāta pagatavošanai |
1 |
1 |
25,71 |
32,20 |
32,20 |
24,15 |
16,10 |
A |
R |
|
L01XX17 |
EU/1/09/552/001 |
Topotecan Teva | Teva Pharma B.V. | koncentrāts injekciju vai infūziju šķīduma pagatavošanai |
1mg/ml |
1 |
29,30 |
36,42 |
32,20 |
24,15 |
16,10 |
A |
|
|
|
L01XX17 |
EU/1/96/027/003 |
Hycamtin | SmithKline Beecham plc | pulveris infūziju šķīduma koncentrāta pagatavošanai |
4 |
1 |
130,73 |
151,18 |
128,80 |
96,60 |
64,40 |
A |
|
|
| Trandolaprilum |
C09AA10 |
97-0390-01 |
Gopten 2mg | Abbott Laboratories Baltics SIA | cietas kapsulas |
2 |
28 |
3,43 |
4,83 |
4,83 |
3,62 |
2,42 |
B |
|
|
C09AA10 |
08-0198-01 |
Gopten 4mg | Abbott Laboratories Baltics SIA | cietas kapsulas |
4 |
28 |
5,52 |
7,56 |
7,56 |
5,67 |
3,78 |
B |
|
|
| Travoprostum |
S01EE04 |
EU/1/01/199/001 |
Travatan | Alcon Laboratories (UK) Ltd. | acu pilieni, šķīdums |
0.04mg/ ml-2.5ml |
1 gab. |
8,83 |
11,82 |
6,79 |
5,09 |
3,40 |
A |
|
| Travoprostum/ Timololum |
S01ED51 |
EU/1/06/338/001 |
DuoTrav | Alcon Laboratories (UK) Ltd. | acu pilieni, šķīdums |
0.04/5mg/ml-2.5ml |
1 gab. |
10,84 |
14,36 |
7,90 |
5,93 |
3,95 |
A |
|
| Triptorelinum |
L02AE04 |
98-0005-01 |
Diphereline 3,75mg | Ipsen Pharma | ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai |
3.75 |
1 |
69,36 |
82,44 |
82,44 |
61,83 |
41,22 |
B |
|
|
L02AE04 |
03-0240-01 |
Diphereline 11,25mg | Ipsen Pharma | ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai |
11.25 |
1 |
216,56 |
247,31 |
247,31 |
185,48 |
123,66 |
B |
|
|
| Valsartanum |
C09CA03 |
02-0391-01 |
Diovan 80mg | Novartis Finland Oy | apvalkotas tabletes |
80 |
28 |
12,29 |
16,15 |
3,02 |
2,27 |
1,51 |
A |
|
|
C09CA03 |
02-0392-01 |
Diovan 160mg | Novartis Finland Oy | apvalkotas tabletes |
160 |
28 |
14,89 |
19,35 |
6,02 |
4,52 |
3,01 |
A |
|
|
| Valsartanum/ Hydrochloro-thiazidum |
C09DA03 |
98-0310-01 |
Co-Diovan 80/12,5mg | Novartis Finland Oy | apvalkotas tabletes |
80/12.5 |
28 |
12,29 |
16,15 |
3,29 |
2,47 |
1,65 |
A |
|
|
C09DA03 |
02-0393-01 |
Co-Diovan 160/12,5mg | Novartis Finland Oy | apvalkotas tabletes |
160/12.5 |
28 |
14,89 |
19,35 |
7,41 |
5,56 |
3,71 |
A |
|
|
|
C09DA03 |
02-0394-01 |
Co-Diovan 160/25mg | Novartis Finland Oy | apvalkotas tabletes |
160/25 |
28 |
14,89 |
19,35 |
7,69 |
5,77 |
3,85 |
A |
|
|
| Vinorelbinum |
L01CA04 |
06-0297-01 |
Vinorelbin "Ebewe" 10mg/ml | Ebewe Pharma GmbH, Nfg.KG | koncentrāts infūziju šķīduma pagatavošanai |
10mg/ml |
1 |
11,69 |
15,41 |
15,41 |
11,56 |
7,71 |
A |
R |
|
L01CA04 |
06-0298-01 |
Vinorelbin "Ebewe" 50mg/5ml | Ebewe Pharma GmbH, Nfg.KG | koncentrāts infūziju šķīduma pagatavošanai |
50mg/5ml |
1 |
64,44 |
76,93 |
76,93 |
57,70 |
38,47 |
A |
R |
|
| VIII asinsreces faktors |
B02BD06 |
99-1017-01 |
Dried Factor VIII Fraction, 8Y | BPL, Bio Products Laboratory | pulveris injekcijām |
250SV/ 10ml |
1 |
27,61 |
34,43 |
34,43 |
25,82 |
17,22 |
A |
R |
|
B02BD06 |
05-0497-01 |
Immunate Baxter 250 IU | Baxter AG | pulveris injekcijām ar šķīdinātāju |
250SV/ 5ml |
1 |
46,95 |
57,18 |
34,43 |
25,82 |
17,22 |
A |
|
|
|
B02BD06 |
99-1017-02 |
Dried Factor VIII Fraction, 8Y | BPL, Bio Products Laboratory | pulveris injekcijām |
500SV/ 20ml |
1 |
56,69 |
68,25 |
68,25 |
51,19 |
34,13 |
A |
R |
|
|
B02BD06 |
05-0498-01 |
Immunate Baxter 500 IU | Baxter AG | pulveris injekcijām ar šķīdinātāju |
500SV/ 5ml |
1 |
93,88 |
109,91 |
68,25 |
51,19 |
34,13 |
A |
|
|
|
B02BD06 |
05-0499-01 |
Immunate Baxter 1000 IU | Baxter AG | pulveris injekcijām ar šķīdinātāju |
1000SV/ 10ml |
1 |
185,96 |
213,04 |
136,49 |
102,37 |
68,25 |
A |
|
|
Veselības ekonomikas centra direktore D.Behmane
4.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
Kompensācijas bāzes cenas un/vai references cenas maiņa Kompensējamo zāļu saraksta medicīniskajām ierīcēm
|
Medicīniskā ierīce |
Identifikācijas Nr. |
Medicīniskās ierīces nosaukums |
Iesniedzējs |
Iepakojuma |
Kompensācijas bāzes cena (Ls) |
Aptiekas cena ar 12% PVN (Ls) |
Kompensācijas summa (Ls) |
Saraksta |
Pazīme |
||
|
100% |
75% |
50% |
|||||||||
| Glikēmijas teststrēmeles |
10/01-007/05-01 |
Contour TS | Bayer SIA |
50 |
10,43 |
13,85 |
11,82 |
8,87 |
5,91 |
A |
|
| Inkontinences līdzekļi |
10/02-021/10-01 |
SENI Super medium | Bella Rīga SIA |
10 |
2,08 |
2,97 |
2,76 |
2,07 |
1,38 |
A |
|
|
10/02-022/10-01 |
SENI Super large | Bella Rīga SIA |
10 |
2,56 |
3,61 |
3,37 |
2,53 |
1,69 |
A |
|
|
|
10/02-024/10-01 |
SENI Super Plus small | Bella Rīga SIA |
10 |
2,68 |
3,77 |
2,75 |
2,06 |
1,38 |
A |
|
|
|
10/02-025/10-01 |
SENI Super Plus medium | Bella Rīga SIA |
10 |
2,87 |
4,02 |
3,14 |
2,36 |
1,57 |
A |
|
|
|
10/02-026/10-01 |
SENI Super Plus large | Bella Rīga SIA |
10 |
3,41 |
4,80 |
3,77 |
2,83 |
1,89 |
A |
|
|
|
10/02-029/10-01 |
SENI Super Trio medium | Bella Rīga SIA |
10 |
3,11 |
4,41 |
3,14 |
2,36 |
1,57 |
A |
|
|
|
10/02-030/10-01 |
SENI Super Trio large | Bella Rīga SIA |
10 |
3,78 |
5,29 |
3,77 |
2,83 |
1,89 |
A |
|
|
|
10/02-052/11-01 |
TENA PANTS super M | SCA Hygiene Products SIA |
12 |
7,81 |
10,51 |
6,69 |
5,02 |
3,35 |
A |
|
|
|
10/02-053/11-01 |
TENA PANTS super L | SCA Hygiene Products SIA |
12 |
8,80 |
11,78 |
8,34 |
6,26 |
4,17 |
A |
|
|
|
10/02-047/11-01 |
TENA PANTS plus S | SCA Hygiene Products SIA |
14 |
6,54 |
8,87 |
7,30 |
5,48 |
3,65 |
A |
|
|
|
10/02-001/07-01 |
ABENA Abri-Flex Plus S | NCare SIA |
14 |
6,54 |
8,87 |
7,30 |
5,48 |
3,65 |
A |
|
|
|
10/02-061/11-01 |
TENA Slip super S | SCA Hygiene Products SIA |
28 |
8,11 |
10,90 |
7,69 |
5,77 |
3,85 |
A |
|
|
|
10/02-062/11-01 |
TENA Slip super M | SCA Hygiene Products SIA |
28 |
8,61 |
11,54 |
8,79 |
6,59 |
4,40 |
A |
|
|
|
10/02-063/11-01 |
TENA Slip super L | SCA Hygiene Products SIA |
28 |
10,42 |
13,84 |
10,56 |
7,92 |
5,28 |
A |
|
|
|
10/02-059/11-01 |
TENA Slip plus M | SCA Hygiene Products SIA |
30 |
7,41 |
9,99 |
8,27 |
6,20 |
4,14 |
A |
|
|
|
10/02-060/11-01 |
TENA Slip plus L | SCA Hygiene Products SIA |
30 |
8,87 |
11,87 |
10,10 |
7,58 |
5,05 |
A |
|
|
Veselības ekonomikas centra direktore D.Behmane
5.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
Saraksta kategorijas maiņa Kompensējamo zāļu saraksta zālēm
|
Zāļu vispārīgais nosaukums |
ATC kodi |
Medikamenta identifikācijas Nr. |
Zāļu nosaukums |
Reģistrācijas apliecības īpašnieks |
Forma |
Stiprums mg |
Iepakojuma lielums |
Kompensācijas bāzes cena (Ls) |
Aptiekas cena ar PVN |
Kompensācijas summa (Ls) |
Saraksta kategorija |
Medikamenta pazīme |
||
|
100% |
75% |
50% |
||||||||||||
| Dorzolamidum |
S01EC03 |
98-0168-01 |
Trusopt 20mg/ml | SIA "Merck Sharp & Dohme Latvija" | acu pilieni, šķīdums |
20mg/ml-5ml |
1 gab. |
5,86 |
8,00 |
6,55 |
4,91 |
3,28 |
A |
|
| Rilmenidinum |
C02AC06 |
02-0344-01 |
Tenaxum 1mg | Les Laboratoires Servier | tabletes |
1 |
30 |
4,50 |
6,24 |
4,42 |
3,32 |
2,21 |
A |
|
|
C02AC06 |
02-0344-02 |
Tenaxum 1mg | Les Laboratoires Servier | tabletes |
1 |
90 |
13,94 |
18,18 |
13,14 |
9,86 |
6,57 |
A |
|
|
Veselības ekonomikas centra direktore D.Behmane
6.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
Identifikācijas numura maiņa Kompensējamo zāļu saraksta zālēm
|
Zāļu vispārīgais nosaukums |
ATC kodi |
Medikamenta identifikācijas Nr. |
Jaunais |
Zāļu nosaukums |
Reģistrācijas apliecības īpašnieks |
Forma |
Stiprums mg |
Iepakojuma lielums |
Kompensācijas bāzes cena (Ls) |
Aptiekas cena ar PVN |
Kompensācijas summa (Ls) |
Saraksta kategorija |
Medikamenta pazīme |
||
|
100% |
75% |
50% |
|||||||||||||
| Atorvastatinum |
C10AA05 |
04-0107-01 |
10-0468-05 |
Tulip 10mg | Sandoz d.d. | apvalkotas tabletes |
10 |
30 |
2,41 |
3,40 |
3,25 |
2,44 |
1,63 |
A |
|
|
C10AA05 |
04-0108-01 |
10-0469-04 |
Tulip 20mg | Sandoz d.d. | apvalkotas tabletes |
20 |
30 |
3,83 |
5,35 |
3,37 |
2,53 |
1,69 |
A |
|
|
| Epirubicinum |
L01DB03 |
07-0400-01 |
07-0398-03 |
Epirubicin Actavis 2mg/ml | Actavis Group | šķīdums injekcijām |
50mg/ 25ml |
1 |
33,10 |
40,89 |
40,89 |
30,67 |
20,45 |
A |
R |
| Oxaliplatinum |
L01XA03 |
07-0397-02 |
07-0396-02 |
Oxaliplatin Actavis 5mg/ml | Actavis Group | pulveris infūziju šķīduma pagatavošanai |
100 |
1 |
34,35 |
42,36 |
42,36 |
31,77 |
21,18 |
A |
R |
| Paclitaxelum |
L01CD01 |
08-0081-01 |
08-0080-02 |
Paclitaxel Actavis 6mg/ml | Actavis Group | koncentrāts infūziju šķīduma pagatavošanai |
100mg/ |
1 |
67,93 |
80,84 |
80,84 |
60,63 |
40,42 |
A |
R |
|
L01CD01 |
08-0083-01 |
08-0080-04 |
Paclitaxel Actavis 6mg/ml | Actavis Group | koncentrāts infūziju šķīduma pagatavošanai |
300mg/ 50ml |
1 |
165,05 |
189,62 |
189,62 |
142,22 |
94,81 |
A |
R |
|
| Pegfilgrastimum |
L03AA13 |
EU/1/02/227/001 |
EU/1/02/227/002 |
Neulasta | Amgen Europe B.V. | šķīdums injekcijām pilnšļircē |
6mg/ 0.6ml |
1 |
637,98 |
719,30 |
719,30 |
539,48 |
359,65 |
B |
|
| Vinorelbinum |
L01CA04 |
08-0157-01 |
08-0156-03 |
Vinorelbine Actavis 50mg/5ml | Actavis Group | koncentrāts infūziju šķīduma pagatavošanai |
50mg/ 5ml |
1 |
64,44 |
76,93 |
76,93 |
57,70 |
38,47 |
A |
R |
Veselības ekonomikas centra direktore D.Behmane
7.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
No Kompensējamo zāļu saraksta svītrotās zāles
|
Zāļu vispārīgais nosaukums |
ATC kods |
Medikamenta identifikācijas Nr. |
Zāļu nosaukums |
Reģistrācijas apliecības īpašnieks |
Forma |
Stip-rums mg |
Iepakojuma lielums |
Kompensācijas bāzes cena (Ls) |
Aptiekas cena ar PVN 12% (Ls) |
Kompensācijas summa (Ls) |
Saraksta kategorija |
Medikamentu pazīme |
||
|
100% |
75% |
50% |
||||||||||||
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
| Anastrozolum |
L02BG03 |
07-0250-04 |
Anastrozole Sandoz 1mg | Sandoz d.d. | apvalkotas tabletes |
1 |
28 |
30,60 |
37,95 |
28,31 |
21,23 |
14,16 |
A |
|
|
L02BG03 |
08-0220-05 |
Anastrozol-ratiopharm 1mg | Ratiopharm GmbH | apvalkotas tabletes |
1 |
30 |
24,13 |
30,34 |
30,34 |
22,76 |
15,17 |
A |
R |
|
| Atenololum |
C07AB03 |
00-0997-01 |
Atenolol Pliva 50mg | Pliva SIA | tabletes |
50 |
30 |
0,77 |
1,12 |
1,12 |
0,84 |
0,56 |
A |
R |
| Atorvastatinum |
C10AA05 |
10-0155-07 |
Atorvastatin-ratiopharm 10mg | Ratiopharm GmbH | apvalkotas tabletes |
10 |
30 |
2,29 |
3,25 |
3,25 |
2,44 |
1,63 |
A |
R |
|
C10AA05 |
10-0156-07 |
Atorvastatin-ratiopharm 20mg | Ratiopharm GmbH | apvalkotas tabletes |
20 |
30 |
3,64 |
5,11 |
5,11 |
3,83 |
2,56 |
A |
R |
|
|
C10AA05 |
10-0157-07 |
Atorvastatin-ratiopharm 40mg | Ratiopharm GmbH | apvalkotas tabletes |
40 |
30 |
6,88 |
9,31 |
9,31 |
6,98 |
4,66 |
A |
R |
|
| Betahistinum |
N07CA01 |
07-0262-05 |
Polvertic 16mg | Medana Pharma SA | tabletes |
16 |
60 |
3,49 |
4,91 |
4,91 |
3,68 |
2,46 |
A |
R |
| Carvedilolum |
C07AG02 |
05-0193-04 |
Carvedigamma 12,5mg | Wörwag Pharma GmbH & Co.KG | apvalkotas tabletes |
12.5 |
30 |
3,71 |
5,20 |
2,88 |
2,16 |
1,44 |
A |
|
|
C07AG02 |
05-0194-04 |
Carvedigamma 25mg | Wörwag Pharma GmbH & Co.KG | apvalkotas tabletes |
25 |
30 |
4,66 |
6,44 |
3,67 |
2,75 |
1,84 |
A |
|
|
| Clopidogrelum |
B01AC04 |
EU/1/09/554/002 |
Clopidogrel ratiopharm | Acino Pharma GmbH | apvalkotas tabletes |
75 |
28 |
6,48 |
8,79 |
8,56 |
6,42 |
4,28 |
A |
|
| Darunavirum |
J05AE10 |
EU/1/06/380/005 |
Prezista | Janssen-Cilag International NV | apvalkotas tabletes |
75 |
480 |
477,77 |
539,86 |
539,86 |
404,90 |
269,93 |
B |
|
|
J05AE10 |
EU/1/06/380/004 |
Prezista | Janssen-Cilag International NV | apvalkotas tabletes |
150 |
240 |
477,77 |
539,86 |
539,86 |
404,90 |
269,93 |
B |
|
|
|
J05AE10 |
EU/1/06/380/001 |
Prezista | Janssen-Cilag International NV | apvalkotas tabletes |
300 |
120 |
433,47 |
490,25 |
490,25 |
367,69 |
245,13 |
B |
|
|
| Erythropoietinum |
B03XA01 |
07-0061-01 |
Eprex 40 000 IU/ml | UAB Johnson&Johnson | šķīdums injekcijām pilnšļircēs |
40 000 SV/ml |
1 |
218,73 |
249,74 |
249,74 |
187,31 |
124,87 |
A |
R |
| Escitalopramum |
N06AB10 |
09-0433-04 |
Escitalopram-ratiopharm 10mg | Ratiopharm GmbH | apvalkotas tabletes |
10 |
30 |
5,86 |
8,00 |
8,00 |
6,00 |
4,00 |
A |
R |
| Gliclazidum |
A10BB09 |
05-0050-03 |
Diaprel MR 30mg | Les Laboratoires Servier | ilgstošas darbības tabletes |
30 |
60 |
4,72 |
6,52 |
5,22 |
3,92 |
2,61 |
A |
|
|
A10BB09 |
05-0050-14 |
Diaprel MR 30mg | Les Laboratoires Servier | ilgstošas darbības tabletes |
30 |
180 |
13,60 |
17,76 |
15,59 |
11,69 |
7,80 |
A |
|
|
| Metforminum |
A10BA02 |
09-0344-12 |
Glucophage 500mg | Merck Sante s.a.s. | apvalkotas tabletes |
500 |
100 |
2,62 |
3,68 |
3,68 |
2,76 |
1,84 |
A |
R |
| Mirtazapinum |
N06AX11 |
05-0208-01 |
Mirtazapine-Teva 30mg | Teva Pharma B.V. | apvalkotas tabletes |
30 |
30 |
4,59 |
6,35 |
6,35 |
4,76 |
3,18 |
A |
R |
| Natrii risedronatum |
M05BA07 |
07-0356-01 |
Actonel 75mg | Sanofi-aventis Latvia SIA | apvalkotas tabletes |
75 |
2 |
22,00 |
27,83 |
11,37 |
8,53 |
5,69 |
A |
|
| Omeprazolum |
A02BC01 |
08-0278-02 |
Omeprazol Sandoz 20mg | Sandoz d.d. | zarnās šķīstošas cietas kapsulas |
20 |
28 |
4,05 |
5,64 |
5,64 |
4,23 |
2,82 |
B |
|
| Paclitaxelum |
L01CD01 |
97-0606-02 |
Taxol 6mg/ml | Bristol-Myers Squibb | koncentrāts infūziju šķīduma pagatavošanai |
30mg/ 5ml |
1 |
24,80 |
31,12 |
24,28 |
18,21 |
12,14 |
A |
|
| Simvastatinum |
C10AA01 |
01-0193-01 |
Vasilip 20mg | KRKA d.d., Novo Mesto | apvalkotas tabletes |
20 |
28 |
5,53 |
7,57 |
1,51 |
1,13 |
0,76 |
A |
|
Veselības ekonomikas centra direktore D.Behmane
8.pielikums
Veselības ekonomikas centra
2011.gada 8.jūnija
rīkojumam Nr.76
No Kompensējamo zāļu saraksta svītrotās medicīniskās ierīces
|
Medicīniskā ierīce |
Identifikācijas Nr. |
Medicīniskās ierīces nosaukums |
Iesniedzējs |
Iepakojuma |
Kompensācijas bāzes cena (Ls) |
Aptiekas cena ar 12% PVN (Ls) |
Kompensācijas summa (Ls) |
Saraksta kategorija |
Pazīme |
||
|
100% |
75% |
50% |
|||||||||
| Inkontinences līdzekļi |
10/02-006/07-01 |
ABENA Abri-Form Super Air Plus M | NCare SIA |
24 |
7,15 |
9,65 |
9,65 |
7,24 |
4,83 |
A |
R |
|
10/02-007/07-01 |
ABENA Abri-Form Super Air Plus L | NCare SIA |
22 |
8,06 |
10,83 |
10,56 |
7,92 |
5,28 |
A |
|
|
Veselības ekonomikas centra direktore D.Behmane